TW201329227A - Foamable alcoholic composition - Google Patents
Foamable alcoholic composition Download PDFInfo
- Publication number
- TW201329227A TW201329227A TW102105324A TW102105324A TW201329227A TW 201329227 A TW201329227 A TW 201329227A TW 102105324 A TW102105324 A TW 102105324A TW 102105324 A TW102105324 A TW 102105324A TW 201329227 A TW201329227 A TW 201329227A
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- alcohol
- peg
- foam
- surfactant
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 189
- 230000001476 alcoholic effect Effects 0.000 title abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 134
- 239000006260 foam Substances 0.000 claims abstract description 125
- 239000004094 surface-active agent Substances 0.000 claims abstract description 79
- 238000005187 foaming Methods 0.000 claims abstract description 63
- 239000003381 stabilizer Substances 0.000 claims abstract description 35
- 229920000642 polymer Polymers 0.000 claims abstract description 30
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920001577 copolymer Polymers 0.000 claims description 83
- -1 perfluorodecylethylcarboxymethyl Chemical group 0.000 claims description 52
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 19
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 claims description 13
- 229920000289 Polyquaternium Polymers 0.000 claims description 8
- 229920001451 polypropylene glycol Polymers 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 229910003849 O-Si Inorganic materials 0.000 claims description 6
- 229910003872 O—Si Inorganic materials 0.000 claims description 6
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- MYIAXOYPDXFLGS-UHFFFAOYSA-N 3-[3-(dimethylamino)propyl]pyrrole-2,5-dione Chemical compound CN(C)CCCC1=CC(=O)NC1=O MYIAXOYPDXFLGS-UHFFFAOYSA-N 0.000 claims description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229910000420 cerium oxide Inorganic materials 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 3
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 claims description 3
- 239000011976 maleic acid Substances 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 claims description 2
- XTDKZSUYCXHXJM-UHFFFAOYSA-N 2-methoxyoxane Chemical compound COC1CCCCO1 XTDKZSUYCXHXJM-UHFFFAOYSA-N 0.000 claims description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- OWMBTIRJFMGPAC-UHFFFAOYSA-N dimethylamino 2-methylprop-2-enoate Chemical compound CN(C)OC(=O)C(C)=C OWMBTIRJFMGPAC-UHFFFAOYSA-N 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 229920001897 terpolymer Polymers 0.000 claims description 2
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 claims 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 claims 1
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 claims 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims 1
- FLCAEMBIQVZWIF-UHFFFAOYSA-N 6-(dimethylamino)-2-methylhex-2-enamide Chemical compound CN(C)CCCC=C(C)C(N)=O FLCAEMBIQVZWIF-UHFFFAOYSA-N 0.000 claims 1
- 239000004721 Polyphenylene oxide Substances 0.000 claims 1
- ROLJWXCAVGNMAK-UHFFFAOYSA-N [Ce]=O Chemical compound [Ce]=O ROLJWXCAVGNMAK-UHFFFAOYSA-N 0.000 claims 1
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- IAPZHENXWLYDIX-UHFFFAOYSA-N hydrazine;methanol Chemical compound OC.NN IAPZHENXWLYDIX-UHFFFAOYSA-N 0.000 claims 1
- ZDPHROOEEOARMN-UHFFFAOYSA-M undecanoate Chemical compound CCCCCCCCCCC([O-])=O ZDPHROOEEOARMN-UHFFFAOYSA-M 0.000 claims 1
- 229940048053 acrylate Drugs 0.000 description 32
- 229920001223 polyethylene glycol Polymers 0.000 description 16
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 239000007788 liquid Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000007789 gas Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- 229910019142 PO4 Inorganic materials 0.000 description 10
- 235000021317 phosphate Nutrition 0.000 description 10
- 229920006322 acrylamide copolymer Polymers 0.000 description 9
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 9
- CKGQJOFAVYEVFG-KXQOOQHDSA-N 2-fluoro-4-[[(1R)-6-[2-[4-[1-(4-methoxyphenyl)-5-methyl-6-oxopyridazin-3-yl]triazol-1-yl]ethoxy]-1-methyl-1-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,4-dihydro-2H-isoquinolin-7-yl]oxy]benzoic acid Chemical compound COc1ccc(cc1)-n1nc(cc(C)c1=O)-c1cn(CCOc2cc3CCN[C@](C)(CC(=O)Nc4nccs4)c3cc2Oc2ccc(C(O)=O)c(F)c2)nn1 CKGQJOFAVYEVFG-KXQOOQHDSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 8
- 239000010452 phosphate Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000003380 propellant Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 6
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 125000000129 anionic group Chemical group 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 6
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 229920006037 cross link polymer Polymers 0.000 description 5
- 239000004872 foam stabilizing agent Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 150000002923 oximes Chemical class 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 4
- 239000001361 adipic acid Substances 0.000 description 4
- 235000011037 adipic acid Nutrition 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- KFYRJJBUHYILSO-YFKPBYRVSA-N (2s)-2-amino-3-dimethylarsanylsulfanyl-3-methylbutanoic acid Chemical compound C[As](C)SC(C)(C)[C@@H](N)C(O)=O KFYRJJBUHYILSO-YFKPBYRVSA-N 0.000 description 3
- ZKYCLDTVJCJYIB-UHFFFAOYSA-N 2-methylidenedecanamide Chemical compound CCCCCCCCC(=C)C(N)=O ZKYCLDTVJCJYIB-UHFFFAOYSA-N 0.000 description 3
- MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical compound C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 3
- 239000003570 air Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N aniline-p-carboxylic acid Natural products NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 3
- 229960003276 erythromycin Drugs 0.000 description 3
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 3
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 2
- GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical compound C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 description 2
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 description 2
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 2
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 2
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 2
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 description 2
- 101150035093 AMPD gene Proteins 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ISHUBLRFUKKKQE-UHFFFAOYSA-O C(C=C)(=O)NCCC[N+](C)(C)C.C(C=C)#N Chemical compound C(C=C)(=O)NCCC[N+](C)(C)C.C(C=C)#N ISHUBLRFUKKKQE-UHFFFAOYSA-O 0.000 description 2
- 108010065839 Capreomycin Proteins 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 239000004099 Chlortetracycline Substances 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- KFVPJMZRRXCXAO-UHFFFAOYSA-N [He].[O] Chemical compound [He].[O] KFVPJMZRRXCXAO-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 2
- 229960004475 chlortetracycline Drugs 0.000 description 2
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 2
- 235000019365 chlortetracycline Nutrition 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 229940120503 dihydroxyacetone Drugs 0.000 description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 150000002194 fatty esters Chemical class 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- GVONPBONFIJAHJ-UHFFFAOYSA-N imidazolidin-4-one Chemical compound O=C1CNCN1 GVONPBONFIJAHJ-UHFFFAOYSA-N 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229910052743 krypton Inorganic materials 0.000 description 2
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 2
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229960004011 methenamine Drugs 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 229960000988 nystatin Drugs 0.000 description 2
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960004448 pentamidine Drugs 0.000 description 2
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229940106026 phenoxyisopropanol Drugs 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 229960001896 pramocaine Drugs 0.000 description 2
- DQKXQSGTHWVTAD-UHFFFAOYSA-N pramocaine Chemical compound C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 DQKXQSGTHWVTAD-UHFFFAOYSA-N 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 229940075466 undecylenate Drugs 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- RJMIEHBSYVWVIN-LLVKDONJSA-N (2r)-2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]propanoic acid Chemical compound C1=CC([C@H](C(O)=O)C)=CC=C1N1C(=O)C2=CC=CC=C2C1 RJMIEHBSYVWVIN-LLVKDONJSA-N 0.000 description 1
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- GUHPRPJDBZHYCJ-SECBINFHSA-N (2s)-2-(5-benzoylthiophen-2-yl)propanoic acid Chemical compound S1C([C@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CC=C1 GUHPRPJDBZHYCJ-SECBINFHSA-N 0.000 description 1
- MDKGKXOCJGEUJW-VIFPVBQESA-N (2s)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-VIFPVBQESA-N 0.000 description 1
- ZEUUPKVZFKBXPW-TWDWGCDDSA-N (2s,3r,4s,5s,6r)-4-amino-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N ZEUUPKVZFKBXPW-TWDWGCDDSA-N 0.000 description 1
- VCOPTHOUUNAYKQ-WBTCAYNUSA-N (3s)-3,6-diamino-n-[[(2s,5s,8e,11s,15s)-15-amino-11-[(6r)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3s)-3,6-diamino-n-[[(2s,5s,8 Chemical compound N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1.N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1 VCOPTHOUUNAYKQ-WBTCAYNUSA-N 0.000 description 1
- XIYOPDCBBDCGOE-IWVLMIASSA-N (4s,4ar,5s,5ar,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C=C1C2=CC=CC(O)=C2C(O)=C2[C@@H]1[C@H](O)[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O XIYOPDCBBDCGOE-IWVLMIASSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- LUOZTUYAYLNGTG-UHFFFAOYSA-N 1,3,2-dioxathiepane-4,7-dione Chemical compound O=C1CCC(=O)OSO1 LUOZTUYAYLNGTG-UHFFFAOYSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- QTKPMCIBUROOGY-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)F QTKPMCIBUROOGY-UHFFFAOYSA-N 0.000 description 1
- FDUFQLNPPGRIKX-UHFFFAOYSA-N 2,2-dimethylpropane-1,3-diol prop-2-enoic acid Chemical compound OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.CC(C)(CO)CO FDUFQLNPPGRIKX-UHFFFAOYSA-N 0.000 description 1
- FCTMFTCHMVUGTA-UHFFFAOYSA-N 2,3,4,4a-tetrahydrocyclopenta[b]pyran Chemical compound O1C=2C(CCC1)C=CC=2 FCTMFTCHMVUGTA-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- TYCOFFBAZNSQOJ-UHFFFAOYSA-N 2-[4-(3-fluorophenyl)phenyl]propanoic acid Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC(F)=C1 TYCOFFBAZNSQOJ-UHFFFAOYSA-N 0.000 description 1
- WGDADRBTCPGSDG-UHFFFAOYSA-N 2-[[4,5-bis(4-chlorophenyl)-1,3-oxazol-2-yl]sulfanyl]propanoic acid Chemical compound O1C(SC(C)C(O)=O)=NC(C=2C=CC(Cl)=CC=2)=C1C1=CC=C(Cl)C=C1 WGDADRBTCPGSDG-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- UXEGPLHYLIPTPE-UHFFFAOYSA-N 2-decoxy-10,10-dimethylundecanoic acid Chemical compound CC(CCCCCCCC(C(=O)O)OCCCCCCCCCC)(C)C UXEGPLHYLIPTPE-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 description 1
- VOQDCMULDZDDLP-UHFFFAOYSA-N 2-methoxy-2,3-dimethyloxane Chemical compound CC1C(OCCC1)(C)OC VOQDCMULDZDDLP-UHFFFAOYSA-N 0.000 description 1
- TUATYNXRYJTQTQ-BVRBKCERSA-N 3,6-diamino-n-[[(2s,5s,8z,11s,15s)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;3,6-diamino-n-[[(2s,5s,8z,11s,15s)-15-a Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H]1C1NC(=N)NCC1.N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H]1C1NC(=N)NCC1 TUATYNXRYJTQTQ-BVRBKCERSA-N 0.000 description 1
- AACHVWXCVWWMSI-UHFFFAOYSA-N 3-hydroxypropyl(trimethyl)azanium Chemical compound C[N+](C)(C)CCCO AACHVWXCVWWMSI-UHFFFAOYSA-N 0.000 description 1
- XHASMJXNUHCHBL-UHFFFAOYSA-N 4-(1-phenylethyl)phenol Chemical compound C=1C=C(O)C=CC=1C(C)C1=CC=CC=C1 XHASMJXNUHCHBL-UHFFFAOYSA-N 0.000 description 1
- FHYNZKLNCPUNEU-UHFFFAOYSA-N 4-[(3,4-dihydroxyphenyl)methyl]-3-[(4-hydroxyphenyl)methyl]oxolan-2-one Chemical compound C1=CC(O)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(O)=C1 FHYNZKLNCPUNEU-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- YWMSSKBMOFPBDM-UHFFFAOYSA-N 4-carbamoylbenzenesulfonyl chloride Chemical compound NC(=O)C1=CC=C(S(Cl)(=O)=O)C=C1 YWMSSKBMOFPBDM-UHFFFAOYSA-N 0.000 description 1
- SBVKVAIECGDBTC-UHFFFAOYSA-N 4-hydroxy-2-methylidenebutanamide Chemical compound NC(=O)C(=C)CCO SBVKVAIECGDBTC-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- YPIFGDQKSSMYHQ-UHFFFAOYSA-N 7,7-dimethyloctanoic acid Chemical compound CC(C)(C)CCCCCC(O)=O YPIFGDQKSSMYHQ-UHFFFAOYSA-N 0.000 description 1
- CMVNWVONJDMTSH-UHFFFAOYSA-N 7-bromo-2-methyl-1h-quinazolin-4-one Chemical compound C1=CC(Br)=CC2=NC(C)=NC(O)=C21 CMVNWVONJDMTSH-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical class C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical class OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- YAVZHCFFUATPRK-YZPBMOCRSA-N Erythromycin stearate Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 YAVZHCFFUATPRK-YZPBMOCRSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- VTUSIVBDOCDNHS-UHFFFAOYSA-N Etidocaine Chemical compound CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C VTUSIVBDOCDNHS-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- DKLKMKYDWHYZTD-UHFFFAOYSA-N Hexylcaine Chemical compound C=1C=CC=CC=1C(=O)OC(C)CNC1CCCCC1 DKLKMKYDWHYZTD-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- ROAIXOJGRFKICW-UHFFFAOYSA-N Methenamine hippurate Chemical compound C1N(C2)CN3CN1CN2C3.OC(=O)CNC(=O)C1=CC=CC=C1 ROAIXOJGRFKICW-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 1
- MMFARLYRROJWLG-UHFFFAOYSA-N N1C=NC=C1.N1NCCC1 Chemical compound N1C=NC=C1.N1NCCC1 MMFARLYRROJWLG-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 244000004005 Nypa fruticans Species 0.000 description 1
- 235000005305 Nypa fruticans Nutrition 0.000 description 1
- IXJPQDXRGGBKRK-RGMNGODLSA-N O=C(O)[C@@H](N)CC1=CC=C(O)C(O)=C1.[P] Chemical compound O=C(O)[C@@H](N)CC1=CC=C(O)C(O)=C1.[P] IXJPQDXRGGBKRK-RGMNGODLSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002593 Polyethylene Glycol 800 Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000589157 Rhizobiales Species 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229910002808 Si–O–Si Inorganic materials 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- SCMSRHIBVBIECI-UHFFFAOYSA-N [2-hydroxy-4-(2-hydroxyethoxy)phenyl]-phenylmethanone Chemical compound OC1=CC(OCCO)=CC=C1C(=O)C1=CC=CC=C1 SCMSRHIBVBIECI-UHFFFAOYSA-N 0.000 description 1
- WYMFBBBPJNXPPL-UHFFFAOYSA-N [Na].C(C=C)(=O)OCCCC Chemical compound [Na].C(C=C)(=O)OCCCC WYMFBBBPJNXPPL-UHFFFAOYSA-N 0.000 description 1
- VVTSZOCINPYFDP-UHFFFAOYSA-N [O].[Ar] Chemical compound [O].[Ar] VVTSZOCINPYFDP-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960004663 alminoprofen Drugs 0.000 description 1
- FPHLBGOJWPEVME-UHFFFAOYSA-N alminoprofen Chemical compound OC(=O)C(C)C1=CC=C(NCC(C)=C)C=C1 FPHLBGOJWPEVME-UHFFFAOYSA-N 0.000 description 1
- SOGAXMICEFXMKE-UHFFFAOYSA-N alpha-Methyl-n-butyl acrylate Natural products CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 229960001656 amikacin sulfate Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 239000006265 aqueous foam Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- NHJPVZLSLOHJDM-UHFFFAOYSA-N azane;butanedioic acid Chemical compound [NH4+].[NH4+].[O-]C(=O)CCC([O-])=O NHJPVZLSLOHJDM-UHFFFAOYSA-N 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 229960005430 benoxaprofen Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229950005608 bucloxic acid Drugs 0.000 description 1
- IJTPQQVCKPZIMV-UHFFFAOYSA-N bucloxic acid Chemical compound ClC1=CC(C(=O)CCC(=O)O)=CC=C1C1CCCCC1 IJTPQQVCKPZIMV-UHFFFAOYSA-N 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960004602 capreomycin Drugs 0.000 description 1
- 229960002968 capreomycin sulfate Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229960002023 chloroprocaine Drugs 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- 229960003185 chlortetracycline hydrochloride Drugs 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- 229960001200 clindamycin hydrochloride Drugs 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 229950010569 dichloroxylenol Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229950010286 diolamine Drugs 0.000 description 1
- GZCKIUIIYCBICZ-UHFFFAOYSA-L disodium;benzene-1,3-dicarboxylate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC(C([O-])=O)=C1 GZCKIUIIYCBICZ-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- MPVXINJRXRIDDB-VCDGYCQFSA-N dodecanoic acid;(2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCCCCCC(O)=O MPVXINJRXRIDDB-VCDGYCQFSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960000385 dyclonine Drugs 0.000 description 1
- BZEWSEKUUPWQDQ-UHFFFAOYSA-N dyclonine Chemical compound C1=CC(OCCCC)=CC=C1C(=O)CCN1CCCCC1 BZEWSEKUUPWQDQ-UHFFFAOYSA-N 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 229960003203 erythromycin estolate Drugs 0.000 description 1
- AWMFUEJKWXESNL-JZBHMOKNSA-N erythromycin estolate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(=O)CC)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AWMFUEJKWXESNL-JZBHMOKNSA-N 0.000 description 1
- 229960004142 erythromycin stearate Drugs 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 229960001618 ethambutol hydrochloride Drugs 0.000 description 1
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- SBBWEQLNKVHYCX-JTQLQIEISA-N ethyl L-tyrosinate Chemical compound CCOC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SBBWEQLNKVHYCX-JTQLQIEISA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- JQPARKNWUCPYTK-UHFFFAOYSA-M ethyl(trimethyl)azanium;2-methylprop-2-enoate Chemical compound CC[N+](C)(C)C.CC(=C)C([O-])=O JQPARKNWUCPYTK-UHFFFAOYSA-M 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 229960003976 etidocaine Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- ZPAKPRAICRBAOD-UHFFFAOYSA-N fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 1
- 229960001395 fenbufen Drugs 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 1
- 229950001284 fluprofen Drugs 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 229960005388 hexylcaine Drugs 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960004187 indoprofen Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- KNISINYMWONJEQ-UHFFFAOYSA-N iodine;phenol Chemical class [I].OC1=CC=CC=C1 KNISINYMWONJEQ-UHFFFAOYSA-N 0.000 description 1
- KRVIMMAOCNANRA-UHFFFAOYSA-N iodine;pyrrolidin-2-one Chemical compound [I].O=C1CCCN1 KRVIMMAOCNANRA-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- KXUHSQYYJYAXGZ-UHFFFAOYSA-N isobutylbenzene Chemical compound CC(C)CC1=CC=CC=C1 KXUHSQYYJYAXGZ-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 150000003903 lactic acid esters Chemical class 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229960001595 lincomycin hydrochloride Drugs 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229960002409 mepivacaine Drugs 0.000 description 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 229940042016 methacycline Drugs 0.000 description 1
- 229960003900 methenamine hippurate Drugs 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- FPTPAIQTXYFGJC-UHFFFAOYSA-N metronidazole hydrochloride Chemical compound Cl.CC1=NC=C([N+]([O-])=O)N1CCO FPTPAIQTXYFGJC-UHFFFAOYSA-N 0.000 description 1
- 229960002395 metronidazole hydrochloride Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229950006616 miroprofen Drugs 0.000 description 1
- OJGQFYYLKNCIJD-UHFFFAOYSA-N miroprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C1=CN(C=CC=C2)C2=N1 OJGQFYYLKNCIJD-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- APNPVBXEWGCCLU-QNRZBPGKSA-N mycomycin Chemical compound OC(=O)C\C=C\C=C/C=C=CC#CC#C APNPVBXEWGCCLU-QNRZBPGKSA-N 0.000 description 1
- IBOBFGGLRNWLIL-UHFFFAOYSA-N n,n-dimethylhexadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)[O-] IBOBFGGLRNWLIL-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229940053050 neomycin sulfate Drugs 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 229960000808 netilmicin Drugs 0.000 description 1
- ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 229960002739 oxaprozin Drugs 0.000 description 1
- OFPXSFXSNFPTHF-UHFFFAOYSA-N oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000005702 oxyalkylene group Chemical group 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
- 229960001914 paromomycin Drugs 0.000 description 1
- XLMFDCKSFJWJTP-UHFFFAOYSA-N pentane-2,3-diol Chemical compound CCC(O)C(C)O XLMFDCKSFJWJTP-UHFFFAOYSA-N 0.000 description 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229960003101 pranoprofen Drugs 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- HPCIWDZYMSZAEZ-UHFFFAOYSA-N prop-2-enyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC=C HPCIWDZYMSZAEZ-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- UKHVLWKBNNSRRR-TYYBGVCCSA-M quaternium-15 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C/C=C/Cl)C3 UKHVLWKBNNSRRR-TYYBGVCCSA-M 0.000 description 1
- 229940096792 quaternium-15 Drugs 0.000 description 1
- 229940127224 quinoline drug Drugs 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 1
- XGRLSUFHELJJAB-JGSYTFBMSA-M sodium;[(2r)-2-hydroxy-3-[(z)-octadec-9-enoyl]oxypropyl] hydrogen phosphate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)([O-])=O XGRLSUFHELJJAB-JGSYTFBMSA-M 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229960004492 suprofen Drugs 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 1
- 229960001312 tiaprofenic acid Drugs 0.000 description 1
- 229950006150 tioxaprofen Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 229960004477 tobramycin sulfate Drugs 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- KQBSGRWMSNFIPG-UHFFFAOYSA-N trioxane Chemical compound C1COOOC1 KQBSGRWMSNFIPG-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 1
- 229940102566 valproate Drugs 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- KOZCZZVUFDCZGG-UHFFFAOYSA-N vinyl benzoate Chemical compound C=COC(=O)C1=CC=CC=C1 KOZCZZVUFDCZGG-UHFFFAOYSA-N 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/16—Foams
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
- C08L83/04—Polysiloxanes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/008—Polymeric surface-active agents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0094—High foaming compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2003—Alcohols; Phenols
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/373—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicones
- C11D3/3738—Alkoxylated silicones
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Fire-Extinguishing Compositions (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Soy Sauces And Products Related Thereto (AREA)
Abstract
Description
本發明係有關可發泡之含醇組成物,且更特別的是,包括選自氟表面活性劑、矽氧烷聚合物表面活性劑及其組合之發泡表面活性劑。 The present invention relates to a foamable alcohol-containing composition and, more particularly, to a foaming surfactant selected from the group consisting of fluorosurfactants, siloxane surfactants, and combinations thereof.
泡沫清潔產品係受歡迎的,部分因為彼等易於散布在表面上。消費者似乎較喜歡發泡肥皂奢侈品。部分由於泡沫的較大表面積,產生與液體或凝膠相同清潔能力的需要較少泡沫。由於泡沫較高的表面張力,適當調配的泡沫產品不會產生傳統凝膠或液態產品遭遇到的滴落及飛濺。這防止損害到使用產品分配器之處的地板及設備器壁。泡沫產品的製造可能比凝膠產品更容易,凝膠產品經常摻入難以處理的粉末狀增稠劑。 Foam cleaning products are popular, in part because they are easily spread on the surface. Consumers seem to prefer luxury soaps. Due in part to the larger surface area of the foam, less foam is required to produce the same cleaning power as a liquid or gel. Due to the high surface tension of the foam, properly formulated foam products do not produce the dripping and splashing experienced by conventional gel or liquid products. This prevents damage to the floor and equipment walls where the product dispenser is used. The manufacture of foam products may be easier than gel products, which are often incorporated into powdery thickeners that are difficult to handle.
水性泡沫清潔產品已被描述過,舉例來說,含有表面活性劑、例如甘醇等的增泡溶劑及至少80重量百分比(重量%)水的泡沫清潔組成物。 Aqueous foam cleaning products have been described, for example, as a foam cleaning composition comprising a surfactant, a suds boosting agent such as glycol, and at least 80 weight percent (wt%) water.
含醇產品當作皮膚的消毒殺菌劑係受歡迎的。然而,以含醇組成物為底的發泡產品就有問題,因為醇據知具有強力消泡性質。儘管液化氣體為底的含醇泡沫狀物質可購 得,但是這些液化氣體產品要製造一般都比非液化氣體泡沫更貴。 Alcohol-containing products are popular as disinfectants for the skin. However, a foamed product based on an alcohol-containing composition is problematic because the alcohol is known to have strong defoaming properties. Although liquefied gas-based alcohol-containing foamy materials are available Yes, but these liquefied gas products are generally more expensive to manufacture than non-liquefied gas foams.
據描述含有水及烷氧基化矽氧化合物之安定的發泡組成物可含有至多30重量%醇,且可保持安定1個月或更久。然而,含醇組成物並未顯示有效的抗微生物性質,除非醇存在50重量百分比或更多的量。 It is described that a stable foaming composition containing water and an alkoxylated oxirane may contain up to 30% by weight of an alcohol and may remain stable for one month or longer. However, the alcohol-containing composition does not exhibit effective antimicrobial properties unless the alcohol is present in an amount of 50% by weight or more.
含有表面活性劑、保濕劑、水及約35至約70重量%醇之可發泡的液態清潔劑已被描述過,然而此組成暴露於空氣時所產生的泡沫將在5至45秒內實質上崩解成液體。 A foamable liquid detergent containing a surfactant, a humectant, water and from about 35 to about 70% by weight of an alcohol has been described, however, the foam produced by exposure of this composition to air will be substantially within 5 to 45 seconds. Disintegrate into a liquid.
皮膚消毒配方據描述包含:(a)總組成之約50至約80重量百分比的醇;(b)約0.02至約5重量%的嵌段共聚物;(c)約5重量%至約25重量%的發泡表面活性劑;(d)約0重量%至約3重量%的增稠劑;(e)約1重量%至約5重量%的乳化劑;(f)約0重量%至約5重量%的防腐劑;(g)約1重量%至約10重量%的清潔劑;(h)約0.5重量%至約5重量%的聚伸烷二醇;(i)約0.05重量%至約5重量%的潤濕劑及/或軟化劑;及(j)約6重量%至約30重量%的水。所教導的發泡表面活性劑為脂肪族琥珀酸磺酸銨、椰子醯胺、例如椰子油二乙醇胺等的烷醇醯胺、氧化十六基二甲基胺等的胺氧化物及例如異硬脂酸兩性丙酸酯(siostereoamphoro-pionate)及月桂醯胺丙基甜菜鹼表面活性劑等的兩性物。 The skin disinfecting formulation is described as comprising: (a) from about 50 to about 80 weight percent of the total composition of the alcohol; (b) from about 0.02 to about 5 weight percent of the block copolymer; (c) from about 5% to about 25 weight percent % of a foaming surfactant; (d) from about 0% by weight to about 3% by weight of a thickener; (e) from about 1% by weight to about 5% by weight of an emulsifier; (f) from about 0% by weight to about 5% by weight of preservative; (g) from about 1% to about 10% by weight of detergent; (h) from about 0.5% to about 5% by weight of polyalkylene glycol; (i) about 0.05% by weight to About 5% by weight of a wetting agent and/or softening agent; and (j) from about 6% by weight to about 30% by weight of water. The foaming surfactants taught are aliphatic ammonium succinate sulfonate, coconut decylamine, amine amides such as coconut oil diethanolamine, amine oxides such as hexadecyl dimethylamine oxide, and the like. Amphoteric acid such as siostereoamphoro-pionate and lauryl propyl betaine surfactant.
市售的非液化氣體含醇泡沫狀物質已利用指定磷酸全 氟烷酯表面活性劑調配且免除發泡泵機制。但是由此製成的泡沫飛逝,且將立即收縮或液化成薄水液層。當含醇泡沫從普通發泡泵機制來分配時,有些泡沫會留在分配器管子內,且,當泡沫破掉時,該組成物經常滴落出分配器。此滴落不僅浪費產物,使分配器四周區域看起來不衛生且可能造成牆壁及地板的損壞,且若產品滴到地上將造成側滑危害。因此,需要安定化的可發泡之含醇組成物。 Commercially available non-liquefied gas alcohol-containing foamy materials have been utilized The fluoroalkyl ester surfactant is formulated and dispenses with the foaming pump mechanism. However, the foam thus produced flies and will immediately shrink or liquefy into a thin aqueous layer. When the alcohol-containing foam is dispensed from a conventional foaming pump mechanism, some of the foam will remain in the dispenser tube and, when the foam breaks, the composition will often drip out of the dispenser. This dripping not only wastes the product, making the area around the dispenser look unsanitary and may cause damage to the walls and floors, and if the product drops to the ground, it will cause a side slip hazard. Therefore, a stabilized foamable alcohol-containing composition is required.
本發明之一或多個具體例提供一種可發泡之含醇組成物,其包含至少約40重量百分比的醇,以此含醇組成物的總重量為基準;及選自矽氧烷聚合物表面活性劑、陰離子性、陽離子性及兩性離子性氟表面活性劑及其組合之發泡表面活性劑;附帶條件為當該發泡表面活性劑包含氟表面活性劑時,該可發泡之含醇組成物進一步包含聚合或寡聚合泡沫安定劑。 One or more specific embodiments of the present invention provide a foamable alcohol-containing composition comprising at least about 40 weight percent alcohol based on the total weight of the alcohol-containing composition; and selected from the group consisting of siloxane polymers a foaming surfactant of a surfactant, an anionic, a cationic and a zwitterionic fluorosurfactant, and combinations thereof; with the proviso that when the foaming surfactant comprises a fluorosurfactant, the foamable The alcohol composition further comprises a polymeric or oligomerized foam stabilizer.
本發明之一或多個具體例進一步提供一種抗微生物組成物,其包含至少約40重量百分比的醇,以此含醇組成物的總重量為基準;及選自矽氧烷聚合物表面活性劑、陰離子性、陽離子性及兩性離子性氟表面活性劑及其組合之發泡表面活性劑;附帶條件為當該發泡表面活性劑包含氟表面活性劑時,該可發泡之含醇組成物進一步包含聚合或寡聚合泡沫安定劑。 One or more embodiments of the present invention further provide an antimicrobial composition comprising at least about 40 weight percent of an alcohol based on the total weight of the alcohol-containing composition; and a surfactant selected from the group consisting of a siloxane polymer surfactant a foaming surfactant of an anionic, cationic and zwitterionic fluorosurfactant and combinations thereof; with the proviso that when the foaming surfactant comprises a fluorosurfactant, the foamable alcohol-containing composition Further comprising a polymeric or oligomeric foam stabilizer.
本發明之一或多個具體例更進一步提供一種形成安定 化含醇泡沫之方法,該方法包含結合醇、選自矽氧烷聚合物表面活性劑、陰離子性、陽離子性及兩性離子性氟表面活性劑及其組合之發泡表面活性劑以形成可發泡之含醇組成物;在混合室中混合該含醇組成物及空氣或鈍性氣體以形成混合物;並使該混合物通過篩網以形成泡沫,至少該發泡含醇組成物包含至少約40重量百分比的醇,以此含醇組成物的總重量為基準,且附帶條件為當該發泡表面活性劑包含氟表面活性劑時,該可發泡之含醇組成物進一步包含聚合或寡聚合泡沫安定劑。 One or more specific examples of the present invention further provide a form of stability A method for forming an alcohol-containing foam comprising a combination of an alcohol, a surfactant selected from the group consisting of a siloxane surfactant, an anionic, a cationic and a zwitterionic fluorosurfactant, and combinations thereof to form a foamable surfactant Soaking the alcohol-containing composition; mixing the alcohol-containing composition and air or a passive gas in a mixing chamber to form a mixture; and passing the mixture through a screen to form a foam, at least the foamed alcohol-containing composition comprising at least about 40 The weight percent alcohol is based on the total weight of the alcohol-containing composition, with the proviso that when the foaming surfactant comprises a fluorosurfactant, the foamable alcohol-containing composition further comprises polymerization or oligomerization. Foam stabilizer.
本發明之一或多個具體例進一步提供一種減少組成物從適於分配該組成物的發泡泵分配器滴落之方法,該方法包含提供一可發泡之組成物,其包含以該含醇組成物的總重量為基準,至少約40重量百分比的醇,以此含醇組成物的總重量為基準,及選自矽氧烷聚合物表面活性劑、陰離子性、陽離子性及兩性離子性氟表面活性劑及其組合之發泡表面活性劑,附帶條件為當該發泡表面活性劑包含氟表面活性劑時,該可發泡之含醇組成物進一步包含聚合或寡聚合泡沫安定劑;提供具有分配器頭的發泡泵分配器;且將該可發泡之組成物置於該泡沫泵分配器中。 One or more embodiments of the present invention further provide a method of reducing the dripping of a composition from a foam pump dispenser suitable for dispensing the composition, the method comprising providing a foamable composition comprising the Based on the total weight of the alcohol composition, at least about 40% by weight of the alcohol, based on the total weight of the alcohol-containing composition, and selected from the group consisting of a siloxane polymer surfactant, anionic, cationic and zwitterionic a foaming surfactant of a fluorosurfactant and combinations thereof, with the proviso that when the foaming surfactant comprises a fluorosurfactant, the foamable alcohol-containing composition further comprises a polymeric or oligomeric foam stabilizer; A foam pump dispenser having a dispenser head is provided; and the foamable composition is placed in the foam pump dispenser.
第1A圖為顯示泡沫剛分配之後,右邊有經安定化的發泡組成物且左邊有未經安定化的發泡組成物之表面的照片。 Fig. 1A is a photograph showing the surface of the foamed composition which has been stabilized after the foam has been dispensed, and which has a stabilized foamed composition on the left side and which has not been stabilized on the left side.
第1B圖為顯示泡沫分配1分鐘之後,右邊有經安定化的發泡組成物且左邊有未經安定化的發泡組成物之表面的照片。 Fig. 1B is a photograph showing the surface of the foamed composition which has been stabilized on the right side and the unstabilized foamed composition on the left side after 1 minute of foam distribution.
第1C圖為顯示泡沫分配3分鐘之後,右邊有經安定化的發泡組成物且左邊有未經安定化的發泡組成物之表面的照片。 Figure 1C is a photograph showing the surface of the foamed composition which was stabilized on the right side and the unstabilized foamed composition on the left side after 3 minutes of foam distribution.
第1D圖為顯示泡沫分配5分鐘之後,右邊有經安定化的發泡組成物且左邊有未經安定化的發泡組成物之表面的照片。 Figure 1D is a photograph showing the surface of the foamed composition which has been stabilized on the right side and the unstabilized foamed composition on the left side after 5 minutes of foam distribution.
第1E圖為顯示泡沫分配1小時之後,右邊有經安定化的發泡組成物且左邊有未經安定化的發泡組成物之表面的照片。 Fig. 1E is a photograph showing the surface of the foamed composition which had been stabilized on the right side and the unstabilized foamed composition on the left side after 1 hour of foam distribution.
根據本發明之可發泡的含醇組成物包括至少一種醇及至少一種發泡表面活性劑。在一個具體例中,該醇為低級烷醇,即含有1至4個碳原子的醇。這些醇類經常具有抗微生物性質。低級烷醇的例子包括,但不限於,甲醇、乙醇、丙醇、異丙醇、丁醇、異丁醇、第三丁醇及其混合物。在一個具體例中,該醇包含乙醇。 The foamable alcohol-containing composition according to the invention comprises at least one alcohol and at least one foaming surfactant. In one embodiment, the alcohol is a lower alkanol, i.e., an alcohol having from 1 to 4 carbon atoms. These alcohols often have antimicrobial properties. Examples of lower alkanols include, but are not limited to, methanol, ethanol, propanol, isopropanol, butanol, isobutanol, tert-butanol, and mixtures thereof. In one embodiment, the alcohol comprises ethanol.
一般而言,該含醇組成物包含至少約40重量百分比(重量%)的醇,以此含醇組成物的總重量為基準。在一個具體例中,該含醇組成物包含至少約45重量百分比的醇,在另一個具體例中,該含醇組成物包含至少約50重 量百分比的醇,且在又另一個具體例中,該含醇組成物包含至少約60重量百分比的醇,以此含醇組成物的總重量為基準。有些例子中可能需要更多或更少的醇,特別是取決於用於該組成物的其他成分及/或量。有些具體例中,該含醇組成物包含約40重量百分比至約98重量百分比的醇,在其他具體例中,該含醇組成物包含約45重量百分比至約95重量百分比的醇,在又另一個具體例中,該含醇組成物包含約50重量百分比至約90重量百分比的醇,在又其他具體例中,該含醇組成物包含約60重量百分比至約80重量百分比的醇,以此含醇組成物的總重量為基準。 Generally, the alcohol-containing composition comprises at least about 40 weight percent (wt%) alcohol based on the total weight of the alcohol-containing composition. In one embodiment, the alcohol-containing composition comprises at least about 45 weight percent alcohol, and in another embodiment, the alcohol-containing composition comprises at least about 50 weights The percentage percentage of alcohol, and in yet another embodiment, the alcohol-containing composition comprises at least about 60 weight percent alcohol based on the total weight of the alcohol-containing composition. Some examples may require more or less alcohol, particularly depending on other ingredients and/or amounts used in the composition. In some embodiments, the alcohol-containing composition comprises from about 40 weight percent to about 98 weight percent alcohol, and in other embodiments, the alcohol-containing composition comprises from about 45 weight percent to about 95 weight percent alcohol, yet another In one embodiment, the alcohol-containing composition comprises from about 50 weight percent to about 90 weight percent alcohol, and in still other embodiments, the alcohol-containing composition comprises from about 60 weight percent to about 80 weight percent alcohol. The total weight of the alcohol-containing composition is based on the basis.
該發泡表面活性劑促成該含醇組成物的發泡性質,且可包括陰離子性、陽離子性、非離子性、兩性離子性或兩性表面活性劑及其締合鹽。在一個具體例中,該發泡表面活性劑包括氟表面活性劑、矽氧烷聚合物表面活性劑或其組合。氟表面活性劑包括含有至少一個氟原子的化合物。氟表面活性劑的例子包括磷酸全氟烷基乙酯、全氟烷基乙基甜菜鹼、氟脂肪族胺氧化物、氟脂肪族丁二酸磺酸鈉、氟脂肪族硬脂酸酯、氟脂肪族磷酸酯、氟脂肪族季鹽及氟脂肪族聚氧乙烯等及其混合物。 The foaming surfactant contributes to the foaming properties of the alcohol-containing composition and may include anionic, cationic, nonionic, zwitterionic or amphoteric surfactants and associated salts thereof. In one embodiment, the lathering surfactant comprises a fluorosurfactant, a siloxane surfactant, or a combination thereof. Fluorosurfactants include compounds containing at least one fluorine atom. Examples of the fluorosurfactant include perfluoroalkylethyl phosphate, perfluoroalkylethylbetaine, fluoroaliphatic amine oxide, sodium fluoroaliphatic succinate, fluoroaliphatic stearate, and fluorine. Aliphatic phosphates, fluoroaliphatic quaternary salts, fluoroaliphatic polyoxyethylenes, and the like, and mixtures thereof.
在一個具體例中,該氟表面活性劑含有帶電物種,即,陰離子性、陽離子性或兩性離子性。含有帶電物種的氟表面活性劑包括磷酸全氟烷基乙酯、全氟烷基乙基甜菜鹼、氟脂肪族胺氧化物、氟脂肪族丁二酸磺酸鈉、氟脂肪 族磷酸酯及氟脂肪族季鹽。氟表面活性劑的指定例子包括DEA-C8-18磷酸全氟烷基乙酯、TEA-C8-18磷酸全氟烷基乙酯、NH4-C8-18磷酸全氟烷基乙酯及C8-18全氟烷基乙基甜菜鹼。 In one embodiment, the fluorosurfactant contains a charged species, i.e., anionic, cationic or zwitterionic. Fluorosurfactants containing charged species include perfluoroalkylethyl phosphate, perfluoroalkylethylbetaine, fluoroaliphatic amine oxides, sodium fluoroaliphatic succinate, fluoroaliphatic phosphates and fluorine Aliphatic quaternary salt. Specific examples of the fluorosurfactant include DEA-C8-18 perfluoroalkylethyl phosphate, TEA-C8-18 perfluoroalkylethyl phosphate, NH 4 -C8-18 perfluoroalkylethyl phosphate, and C8- 18 perfluoroalkylethyl betaine.
在一個具體例中,該氟表面活性劑包括可藉由下式表示之化合物[F3CF2C-(CF2CF2)x-CH2CH2-O-P2O3]-[R1]+ In one embodiment, the fluorosurfactant comprises a compound [F 3 CF 2 C-(CF 2 CF 2 ) x -CH 2 CH 2 -OP 2 O 3 ] - [R 1 ] which can be represented by the formula +
其中[R1]+包括DEA、TEA、NH4或甜菜鹼,且其中x為約4至約18的整數。 Wherein [R 1 ] + includes DEA, TEA, NH 4 or betaine, and wherein x is an integer from about 4 to about 18.
矽氧烷聚合物表面活性劑的特徵大體上為聚合物骨幹中含有一或更多個Si-O-Si鍵聯。該矽氧烷聚合物表面活性劑可以或可不包括氟原子。因此,有些發泡表面活性劑分類成氟表面活性劑及矽氧烷聚合物表面活性劑。矽氧烷聚合物表面活性劑包括有機聚矽氧烷聚二甲基矽氧烷多元醇、矽氧甲醇流體、矽氧聚醚、烷基甲基矽氧烷、聚二甲基矽氧烷胺(amodimethicone)、三矽氧烷乙氧基化物、聚二甲基矽氧烷醇、季銨化矽氧表面活性劑、聚矽氧、矽氧交聯聚合物及矽氧蠟。 The siloxane polymer surfactant is generally characterized by one or more Si-O-Si linkages in the polymer backbone. The oxane polymer surfactant may or may not include a fluorine atom. Therefore, some foaming surfactants are classified into fluorosurfactants and siloxane surfactants. The oxoxane polymer surfactants include organopolyoxyalkylene polydimethyl methoxy olefin polyols, oxime methanol fluids, oxime polyethers, alkyl methyl oxiranes, polydimethyl methoxy oxyalkylamines. (amodimethicone), trioxane ethoxylate, polydimethyl methoxyalkanol, quaternized cerium oxide surfactant, polyfluorene oxide, argon-oxygen cross-linking polymer and fluorinated wax.
矽氧烷聚合物表面活性劑的例子包括聚二甲基矽氧烷PEG-7十一烯酸酯、PEG-10聚二甲基矽氧烷、PEG-8聚二甲基矽氧烷、PEG-12聚二甲基矽氧烷、全氟壬基乙基羧基癸基PEG 10、PEG-20/PPG-23聚二甲基矽氧烷、PEG-11甲醚聚二甲基矽氧烷、雙-PEG/PPG-20/20聚二甲基矽氧烷、四級矽氧(silicone quats)、PEG-9聚二甲基 矽氧烷、PPG-12聚二甲基矽氧烷、氟PEG-8聚二甲基矽氧烷、PEG 23/PPG 6聚二甲基矽氧烷、PEG 20/PPG 23聚二甲基矽氧烷、PEG 17聚二甲基矽氧烷、PEG 5/PPG 3聚甲基矽氧烷、雙-PEG 20聚二甲基矽氧烷、PEG/PPG20/15聚二甲基矽氧烷共聚多元醇及磺基丁二酸酯摻混物、PEG-8聚二甲基矽氧烷\二聚酸摻混物、PEG-8聚二甲基矽氧烷\脂肪酸摻混物、PEG-8聚二甲基矽氧烷\冷壓蔬菜油\聚季銨鹽(polyquaternium)摻混物、無規嵌段聚合物及其混合物。 Examples of the oxoxane polymer surfactant include polydimethyl methoxy ane PEG-7 undecylenate, PEG-10 polydimethyl methoxy olefin, PEG-8 polydimethyl decane, PEG. -12 polydimethyloxane, perfluorodecylethylcarboxymethyl PEG 10, PEG-20/PPG-23 polydimethyloxane, PEG-11 methyl ether polydimethyloxane, Bi-PEG/PPG-20/20 polydimethyloxane, silicon quats, PEG-9 polydimethyl Oxane, PPG-12 polydimethyloxane, fluoroPEG-8 polydimethyloxane, PEG 23/PPG 6 polydimethyloxane, PEG 20/PPG 23 polydimethylhydrazine Oxyalkane, PEG 17 polydimethyloxane, PEG 5/PPG 3 polymethyl decane, bis-PEG 20 polydimethyl decane, PEG/PPG20/15 polydimethyl siloxane copolymerization Polyol and sulfosuccinate blend, PEG-8 polydimethyloxane\dimer acid blend, PEG-8 polydimethyloxane\fatty acid blend, PEG-8 Polydimethyloxane\cold vegetable oil\polyquaternium blend, random block polymer and mixtures thereof.
在一個具體例中,該矽氧烷聚合物表面活性劑包括可藉由下式表示之化合物R2-Si(CH3)2-[O-Si(CH3)2]a-[O-Si(CH3)R3]b-O-Si(CH3)2-R2 In one embodiment, the siloxane polymer surfactant comprises a compound R 2 -Si(CH 3 ) 2 -[O-Si(CH 3 ) 2 ] a -[O-Si (CH 3 )R 3 ] b -O-Si(CH 3 ) 2 -R 2
其中R2及R3獨立地包括甲基或可藉由下式表示的部分-(CH2)3-O-(CH2CH2O)c-[CH2CH(CH3)O]d-CH2CH2O)eH Wherein R 2 and R 3 independently include a methyl group or a moiety -(CH 2 ) 3 -O-(CH 2 CH 2 O) c -[CH 2 CH(CH 3 )O] d - which may be represented by the formula CH 2 CH 2 O) e H
附帶條件為R2及R3不同時為CH3,其中a為約3至約21的整數,b為約1至約7的整數,c為約0至約40的整數,d為約0至約40的整數,及e為約0至約40的整數,附帶條件為a3xb且c+d+e5。 With the proviso that R 2 and R 3 are not simultaneously CH 3 , wherein a is an integer from about 3 to about 21, b is an integer from about 1 to about 7, c is an integer from about 0 to about 40, and d is from about 0 to An integer of about 40, and e is an integer from about 0 to about 40, with the condition a 3xb and c+d+e 5.
發泡表面活性劑的量並沒有特別的限定,只要存在能產生發泡的有效量即可。在某些具體例中,能產生發泡的有效量可能會變動,取決於存在的醇及其他成分的量。在一或多個具體例中,該含醇組成物包括至少約0.002重量%的發泡表面活性劑,以此含醇組成物的總重量為基準。 在另一個具體例中,該含醇組成物包括至少約0.01重量%的發泡表面活性劑,以此含醇組成物的總重量為基準。在又另一個具體例中,該含醇組成物包括至少約0.05重量%的發泡表面活性劑,以此含醇組成物的總重量為基準。 The amount of the foaming surfactant is not particularly limited as long as an effective amount capable of foaming is present. In some embodiments, the effective amount of foaming that can be produced may vary, depending on the amount of alcohol and other ingredients present. In one or more embodiments, the alcohol-containing composition comprises at least about 0.002% by weight of a foaming surfactant based on the total weight of the alcohol-containing composition. In another embodiment, the alcohol-containing composition comprises at least about 0.01% by weight of a foaming surfactant based on the total weight of the alcohol-containing composition. In yet another embodiment, the alcohol-containing composition comprises at least about 0.05% by weight of a foaming surfactant based on the total weight of the alcohol-containing composition.
在一個具體例中,該發泡表面活性劑存在約0.002重量百分比至約4重量百分比的量,以此含醇組成物的總重量為基準。在另一個具體例中,該發泡表面活性劑存在約0.01重量百分比至約2重量百分比的量,以此含醇組成物的總重量為基準。可預見較大量也可有效產生泡沫。有關列舉成分的所有重量皆係以活性量為基準,因此,不包括市售材料中包括的載體或副產物,除非另行指明。 In one embodiment, the foaming surfactant is present in an amount from about 0.002 weight percent to about 4 weight percent based on the total weight of the alcohol-containing composition. In another embodiment, the foaming surfactant is present in an amount from about 0.01 weight percent to about 2 weight percent based on the total weight of the alcohol-containing composition. It is foreseeable that a larger amount can also effectively produce a foam. All weights of the listed ingredients are based on the active amount and, therefore, do not include the carriers or by-products included in the commercially available materials unless otherwise indicated.
有些具體例中,就經濟或其他理由理想上可限制氟表面活性劑的量。有利地,安定的泡沫可由含有大於約60重量%醇及約0.002至約0.5重量%的氟表面活性劑之根據本發明的組成物來製造,以此組成物的總重量為基準。有些具體例中,該可發泡之組成物包括大於約65重量%醇及約0.002至約0.4重量%的氟表面活性劑,以此組成物的總重量為基準。 In some specific examples, the amount of fluorosurfactant is ideally limited for economic or other reasons. Advantageously, the stabilized foam can be made from a composition according to the invention containing greater than about 60% by weight alcohol and from about 0.002 to about 0.5% by weight fluorosurfactant, based on the total weight of the composition. In some embodiments, the foamable composition comprises greater than about 65% by weight alcohol and from about 0.002 to about 0.4% by weight fluorosurfactant, based on the total weight of the composition.
在其他具體例中,理想上可使用較大量的發泡表面活性劑。舉例來說,有些本發明的發泡含醇組成物包括應用於表面然後洗掉之清潔或衛生產品的具體例中,可使用較大量的發泡表面活性劑。在這些具體例中,以該組成物的總重量為基準,發泡表面活性劑的量存在至多約35重量%。 In other embodiments, it may be desirable to use larger amounts of lathering surfactant. For example, some of the foamed alcohol-containing compositions of the present invention include specific examples of cleaning or hygiene products that are applied to the surface and then washed away, and larger amounts of foaming surfactants can be used. In these specific examples, the amount of the foaming surfactant is present in an amount of up to about 35% by weight based on the total weight of the composition.
在一或更多個具體例中,將該發泡表面活性劑直接加至該含醇組成物。在其他具體例中,該發泡表面活性劑以溶液或乳液形式加至該含醇組成物。換句話說,該發泡表面活性劑可與載劑預混合以形成發泡表面活性劑溶液或乳液,附帶條件為該載劑不會有害地影響該含醇組成物的發泡性質。載劑的例子包括水、醇、例如丙二醇或乙二醇等的二醇類、酮類、線性及/或環狀烴類、三酸甘油脂類、碳酸酯類、矽氧類、烯類、例如醋酸酯等的酯類、苯甲酸酯類、脂肪酯類、甘油酯類、醚類、醯胺類、聚乙二醇類及PEG/PPG共聚物類、例如生理食鹽水等的無機鹽溶液及其混合物。要了解的是,當該發泡表面活性劑預混合而形成發泡表面活性劑溶液或乳液時,可選擇加至該含醇組成物的溶液或乳液量使發泡表面活性劑的量落在上述範圍內。 In one or more specific examples, the foaming surfactant is added directly to the alcohol-containing composition. In other embodiments, the foaming surfactant is added to the alcohol-containing composition in the form of a solution or emulsion. In other words, the foaming surfactant can be premixed with the carrier to form a foaming surfactant solution or emulsion, provided that the carrier does not deleteriously affect the foaming properties of the alcohol-containing composition. Examples of the carrier include water, alcohols, glycols such as propylene glycol or ethylene glycol, ketones, linear and/or cyclic hydrocarbons, triglycerides, carbonates, oximes, alkenes, For example, esters such as acetate, benzoates, fatty esters, glycerides, ethers, guanamines, polyethylene glycols, and PEG/PPG copolymers, for example, inorganic salt solutions such as physiological saline. And mixtures thereof. It is to be understood that when the foaming surfactant is premixed to form a foaming surfactant solution or emulsion, the amount of the solution or emulsion added to the alcohol-containing composition may be selected such that the amount of the foaming surfactant falls. Within the above range.
發泡表面活性劑溶液或乳液在市場上可購得,舉例來說註冊商標Masurf® FS-115的氟脂肪族磷酸酯在水中的14重量%溶液、Masurf® FS-130的氟脂肪族磷酸酯在水中的28重量%溶液,可購自Mason Chemical公司。如此技藝中已知的,矽氧烷表面活性劑也可在市場上可購得。 A foaming surfactant solution or emulsion is commercially available, for example, a 14% by weight solution of a fluoroaliphatic phosphate of the registered trademark Masurf ® FS-115 in water, a fluoroaliphatic phosphate of Masurf ® FS-130. A 28% by weight solution in water is available from Mason Chemical Company. As is known in the art, oxoxane surfactants are also commercially available.
有些具體例中,本發明的含醇組成物進一步包括至少一泡沫安定劑。在一個具體例中,當該發泡表面活性劑包含氟表面活性劑時,該泡沫安定劑可選自聚合或寡聚合泡沫安定劑。在另一個具體例中,當該發泡表面活性劑包含矽氧烷聚合物表面活性劑時,該泡沫安定劑係選擇性的, 且可為聚合性或非聚合性。在一個具體例中,該泡沫安定劑包含陽離陽離子性寡聚合或聚合物。 In some embodiments, the alcohol-containing composition of the present invention further comprises at least one foam stabilizer. In one embodiment, when the foaming surfactant comprises a fluorosurfactant, the foam stabilizer can be selected from polymeric or oligomeric foam stabilizers. In another embodiment, when the foaming surfactant comprises a siloxane surfactant, the foam stabilizer is selective, It may be polymerizable or non-polymerizable. In one embodiment, the foam stabilizer comprises a cationic cationic oligomer or polymer.
有利地,這些具體例的含醇組成物與不含該泡沫安定劑的含醇組成物作比較將顯示改良的泡沫安定性。而「泡沫安定性」意指泡沫破掉變成液體耗費的時間長度。 Advantageously, comparison of the alcohol-containing compositions of these specific examples with the alcohol-containing compositions that do not contain the foam stabilizer will exhibit improved foam stability. "Foam stability" means the length of time it takes for a bubble to break into a liquid.
聚合性泡沫安定劑包括聚季銨鹽(polyquaternium)聚合物。一般而言,聚季銨鹽聚合物係標示成CTFA。聚季銨鹽聚合物的特徵可為含有四級銨基。聚季銨鹽的非限定例子包括下文中表1列舉者,包括INCI名稱及學術名稱。 Polymeric foam stabilizers include polyquaternium polymers. In general, the polyquaternium polymer is labeled as CTFA. The polyquaternium polymer can be characterized as containing a quaternary ammonium group. Non-limiting examples of polyquaterniums include those listed below in Table 1, including the INCI name and academic name.
在一或更多個具體例中,該聚季銨鹽聚合物包括乙烯基吡咯烷酮及二甲基胺基甲基丙烯酸酯的季銨化共聚物、乙烯基吡咯烷酮及二甲胺基丙基甲基丙烯醯胺之經疏水改質的季銨化共聚物,或其混合物。 In one or more specific examples, the polyquaternium polymer comprises a quaternized copolymer of vinylpyrrolidone and dimethylamino methacrylate, vinylpyrrolidone and dimethylaminopropylmethyl A hydrophobically modified quaternized copolymer of acrylamide, or a mixture thereof.
在一個具體例中,該聚季銨鹽聚合物具有1,000至5,000,000的分子量,在另一個具體例中,約1500至約2,500,000且在又另一個具體例中,約1,000,000至約 2,000,000。 In one embodiment, the polyquaternium polymer has a molecular weight of from 1,000 to 5,000,000, in another embodiment, from about 1500 to about 2,500,000 and in yet another embodiment, from about 1,000,000 to about 2,000,000.
其他可操作以改良泡沫品質及/或安定性的泡沫安定劑包括乙烯基己內醯胺(VCL)、乙烯基吡咯烷酮(VP)及丙烯酸二烷胺基烷酯的三元聚合物,包括VP/乙烯基己內醯胺/二甲胺基丙基甲基丙烯醯胺共聚物。又另一種泡沫安定劑包括異丁烯/二甲胺基丙基順丁烯二醯亞胺/乙氧基化順丁烯二醯亞胺/順丁烯二酸共聚物。有時候將各種不同的泡沫安定劑稱為成膜聚合物。 Other foam stabilizers which are operable to improve foam quality and/or stability include terpolymers of vinyl caprolactam (VCL), vinylpyrrolidone (VP) and dialkylaminoalkyl acrylates, including VP/ Vinyl caprolactam / dimethylaminopropyl methacrylamide copolymer. Yet another foam stabilizer comprises isobutylene/dimethylaminopropyl maleimide/ethoxylated maleimide/maleic acid copolymer. A variety of different foam stabilizers are sometimes referred to as film-forming polymers.
又其他的泡沫安定劑包括丙烯醯胺/丙烯酸銨共聚物、丙烯醯胺/DMAPA丙烯酸酯/甲氧基PEG甲基丙烯酸酯共聚物、丙烯醯胺/丙烯醯基二甲基牛磺酸鈉/丙烯酸共聚物、氯化丙烯醯胺基丙基三甲基銨/丙烯醯胺共聚物、氯化丙烯醯胺基丙基三甲基銨/丙烯酸酯共聚物、丙烯酸酯/甲基丙烯酸乙醯乙氧基乙酯共聚物、丙烯酸酯/丙烯醯胺共聚物、丙烯酸酯共聚物、丙烯酸酯/C1-2丁二酸酯/羥基丙烯酸酯共聚物、丙烯酸酯/氧化乙胺甲基丙烯酸酯共聚物、丙烯酸酯/月桂烷基丙烯酸酯/硬脂醯基丙烯酸酯/氧化乙胺甲基丙烯酸酯共聚物、丙烯酸酯/辛基丙烯醯胺共聚物、丙烯酸酯/辛基丙烯醯胺/二苯基聚二甲基矽氧烷胺共聚物、丙烯酸酯/聚三甲基矽氧基甲基丙烯酸酯共聚物、丙烯酸酯/硬脂醯基丙烯酸酯/氧化乙胺甲基丙烯酸酯共聚物、丙烯酸酯/甲基丙烯酸三氟丙酯/聚三甲基矽氧基甲基丙烯酸酯共聚物、丙烯酸酯/VA共聚物、丙烯酸酯/VP共聚物、己二酸/二乙三胺共聚物、己二酸/二甲胺基 羥丙基二乙三胺共聚物、己二酸/環氧丙基二乙三胺共聚物、己二酸/間苯二甲酸/新戊二醇/三羥甲基丙烷共聚物、硬脂酸烯丙脂/VA共聚物、胺乙丙烯酸磷酸酯/丙烯酸酯共聚物、胺乙基丙二醇-丙烯酸酯/丙烯醯胺共聚物、胺乙基丙二醇-AMPD-丙烯酸酯/二丙酮丙烯醯胺共聚物、銨VA/丙烯酸酯共聚物、聚二甲基矽氧烷胺/矽個半氧烷共聚物、AMPD-丙烯酸酯/二丙酮丙烯醯胺共聚物、AMP-丙烯酸酯/甲基丙烯酸烯丙酯共聚物、AMP-丙烯酸酯/丙烯酸C-18烷酯/C1-8烷基丙烯醯胺共聚物、AMP-丙烯酸酯/二丙酮丙烯醯胺共聚物、AMP-丙烯酸酯/甲基丙烯酸二甲基胺乙酯共聚物、桿狀細菌/米糠萃取物/大豆萃取物發酵濾液、山萮基甲基丙烯酸酯/氧化乙胺甲基丙烯酸酯共聚物、雙-丁氧基聚二甲基矽氧烷胺/PEG-60共聚物、雙-異丁基PEG-14/聚二甲基矽氧烷胺共聚物、雙-異丁基PEG-15/聚二甲基矽氧烷胺共聚物、丙烯酸丁酯/甲基丙烯酸乙基己酯共聚物、丙烯酸丁酯/羥丙基聚二甲基矽氧烷胺丙烯酸酯共聚物、乙烯的丁酯/MA共聚物、PVM的丁酯/MA共聚物、鈣/鈉PVM/MA共聚物、幾丁胺醣、幾丁胺醣乳酸酯、玉米澱粉/丙烯醯胺/丙烯酸鈉共聚物、脫氫黃原膠、二乙二醇胺、表氯醇/六氫吡嗪共聚物、聚二甲基矽氧烷交聯共聚物、聚二甲基矽氧烷/矽個半氧烷共聚物、二苯基聚二甲基矽氧烷胺、PVM的乙酯/MA共聚物、氯化乙基三甲基銨甲基丙烯酸/羥乙基丙烯醯胺共聚物、水解麥蛋白/PVP交聯聚合物、羥丙基聚二甲基矽氧烷基丙 基丙烯酸酯共聚物、羥丙基三甲基銨水解玉米澱粉、異丁烯/乙基順丁烯二醯亞胺/羥乙基順丁烯二醯亞胺共聚物、異丁烯/MA共聚物、甲基丙烯酸異丁酯/甲基丙烯酸三氟乙酯/雙-羥丙基聚二甲基矽氧烷丙烯酸酯共聚物、PVM的異丙酯/MA共聚物、月桂烷基丙烯酸酯交聯聚合物、月桂烷基甲基丙烯酸酯/乙二醇二甲基丙烯酸酯交聯聚合物、月桂烷基PEG-9聚二甲基矽氧乙基聚二甲基矽氧烷、甲基丙烯酸/丙烯醯胺甲基丙磺酸鈉共聚物、甲基丙烯醯基乙基甜菜鹼/丙烯酸酯共聚物、甲氧基聚二甲基矽氧烷胺/矽個半氧烷共聚物、甲氧基PEG-114/聚ε-己內酯、肉豆蔻酸/棕櫚酸/硬脂酸/蓖酸/二十碳烷二酸甘油酯、辛基丙烯醯胺/丙烯酸酯/甲基丙烯酸丁基胺乙酯共聚物、PEG-800/聚乙烯醇共聚物、PEG/PPG-25/25聚二甲基矽氧烷胺/丙烯酸酯共聚物、PEG-8/SMDI共聚物、聚丙烯醯胺、聚丙烯酸酯-6、聚丙烯酸酯-8、聚丙烯酸酯-9、聚丙烯酸酯-15、聚丙烯酸酯-16、聚丙烯酸酯-17、聚丙烯酸酯-18、聚丙烯酸酯-19、聚β-苯胺/戊二酸交聯聚合物、聚對苯二甲酸丁二酯、聚酯-1、聚丙烯酸乙酯、聚對苯二甲酸乙二酯、聚醯亞胺-1、聚甲基丙烯醯基乙基甜菜鹼、聚季戊四醇對苯二甲酸酯、聚全氟全氫菲、聚季銨鹽-4/羥丙基澱粉共聚物、聚胺基甲酸酯-1、聚胺基甲酸酯-6、聚胺基甲酸酯-10、聚胺基甲酸酯-18、聚胺基甲酸酯-19、聚醋酸乙烯酯、聚乙烯基丁醛、聚乙烯基己內醯胺、聚乙烯基甲醯胺、聚乙烯基咪唑鎓醋酸酯、聚乙烯基甲基醚、PVM的 丁基酯鉀鹽/MA共聚物、PVM的乙基酯鉀鹽/MA共聚物、PPG-70聚甘油基-10醚、PPG-12/SMDI共聚物、PPG-51/SMDI共聚物、PVM/MA共聚物、PVP/VA/衣康酸共聚物、PVP/VA/丙酸乙烯酯共聚物、根瘤菌膠、松脂丙烯酸酯、蟲膠、矽氧季銨-16/縮水甘油氧基聚二甲基矽氧烷交聯聚合物、PVM的丁酯鈉鹽/MA共聚物、PVM的乙酯鈉鹽/MA共聚物、聚丙烯酸鈉、聚γ-胺基戊二酸鈉、大豆蛋白苯二甲酸酯、蘋婆膠(sterculia urens gum)、對苯二甲酸/間苯二甲酸/間苯二甲酸磺酸鈉/乙二醇共聚物、二羥甲基丙烷三丙烯酸酯、三甲基矽氧基矽烷基胺基甲醯基普魯蘭多醣(pullulan)、VA/巴豆酸酯共聚物、VA/巴豆酸酯/甲基丙烯醯氧基苯甲酮-1共聚物、VA/巴豆酸酯/新癸酸乙烯酯共聚物、VA/巴豆酸酯/丙酸乙烯酯共聚物、VA/DBM共聚物、VA/苯甲酸乙烯基丁酯/巴豆酸酯共聚物、乙烯胺/乙烯醇共聚物、乙烯基己內醯胺/VP/甲基丙烯酸二甲基胺乙酯共聚物、VP/丙烯酸酯/月桂烷基甲基丙烯酸酯共聚物、VP/甲基丙烯酸二甲胺基乙酯共聚物、VP/DMAPA丙烯酸酯共聚物、VP/十六烯共聚物、VP/甲基丙烯醯胺/乙烯基咪唑共聚物、VP/VA共聚物、VP/乙烯基己內醯胺/DMAPA丙烯酸酯共聚物、酵母棕櫚酸酯、例如苯丙基二甲基矽氧基矽酸酯等之矽為底的聚合物或樹脂、三甲基矽氧基矽酸酯、環戊矽氧烷、三甲基矽氧基矽酸酯、二異硬脂醯基三羥甲基丙烷矽氧基矽酸酯、乙烯基聚二甲基矽氧烷交聯聚合物/摻混物及烷基鯨蠟烷基聚二 甲基矽氧烷交聯聚合物。 Still other foam stabilizers include acrylamide/ammonium acrylate copolymer, acrylamide/DMAPA acrylate/methoxy PEG methacrylate copolymer, acrylamide/acryloyldimethyl taurate/ Acrylic copolymer, acrylonitrile acrylamidopropyltrimethylammonium/acrylamide copolymer, acrylonitrile acrylamidopropyltrimethylammonium/acrylate copolymer, acrylate/ethyl methacrylate Oxyethyl ester copolymer, acrylate/acrylamide copolymer, acrylate copolymer, acrylate/C1-2 succinate/hydroxy acrylate copolymer, acrylate/ethylamine methacrylate copolymer , acrylate/lauryl acrylate/stearyl acrylate/ethylamine methacrylate copolymer, acrylate/octyl acrylamide copolymer, acrylate/octyl acrylamide/diphenyl Polydimethyl methoxyalkylamine copolymer, acrylate/polytrimethyl methoxy methacrylate copolymer, acrylate/stearyl acrylate/ethylamine methacrylate copolymer, acrylate /Trifluoropropyl methacrylate / polytrimethyl Oxy methacrylate copolymers, acrylate / VA copolymer, acrylates / VP copolymer, adipic acid / diethylenetriamine copolymer, adipic acid / dimethylamino Hydroxypropyldiethylenetriamine copolymer, adipic acid/epoxypropyldiethylenetriamine copolymer, adipic acid/isophthalic acid/neopentyl glycol/trimethylolpropane copolymer, stearic acid Allyl ester / VA copolymer, amine acetyl acrylate / acrylate copolymer, amine ethyl propylene glycol - acrylate / acrylamide copolymer, amine ethyl propylene glycol - AMPD - acrylate / diacetone acrylamide copolymer , ammonium VA / acrylate copolymer, polydimethyl methoxy oxyalkylamine / fluorene heptane copolymer, AMPD - acrylate / diacetone acrylamide copolymer, AMP - acrylate / allyl methacrylate Copolymer, AMP-acrylate/C-18 alkyl acrylate/C1-8 alkyl acrylamide copolymer, AMP-acrylate/diacetone acrylamide copolymer, AMP-acrylate/dimethyl methacrylate Amine ethyl ester copolymer, rod-shaped bacteria / rice bran extract / soybean extract fermentation filtrate, behenyl methacrylate / ethylene oxide methacrylate copolymer, bis-butoxy polydimethyl decane Amine/PEG-60 copolymer, bis-isobutyl PEG-14/polydimethyloxyalkylamine copolymer, bis-isobutyl PEG-15/polydimethyl Oxyalkylamine copolymer, butyl acrylate/ethylhexyl methacrylate copolymer, butyl acrylate/hydroxypropyl polydimethyloxy oxyalkylamine acrylate copolymer, butyl acrylate/MA copolymer, PVM Butyl ester/MA copolymer, calcium/sodium PVM/MA copolymer, chitosan sugar, chitosan lactic acid ester, corn starch/acrylamide/sodium acrylate copolymer, dehydrogenated xanthan gum, diethyl Diolamine, epichlorohydrin/hexahydropyrazine copolymer, polydimethyloxane cross-linked copolymer, polydimethyl methoxy oxane/co-semi-oxyalkylene copolymer, diphenyl polydimethyl Oxyalkyleneamine, ethyl acetate/MA copolymer of PVM, ethyltrimethylammonium methacrylate/hydroxyethyl acrylamide copolymer, hydrolyzed wheat protein/PVP crosspolymer, hydroxypropyl poly Methyl methoxyalkyl Acrylate copolymer, hydroxypropyltrimethylammonium hydrolyzed corn starch, isobutylene/ethyl maleimide/hydroxyethyl maleimide copolymer, isobutylene/MA copolymer, methyl Isobutyl acrylate/trifluoroethyl methacrylate/bis-hydroxypropyl polydimethyl decane acrylate copolymer, isopropyl ester/MA copolymer of PVM, lauryl acrylate crosspolymer, Lauryl alkyl methacrylate/ethylene glycol dimethacrylate crosspolymer, lauryl PEG-9 polydimethyl oxirane polydimethyl oxane, methacrylic acid / acrylamide Sodium methylpropane sulfonate copolymer, methacryl decyl ethyl betaine/acrylate copolymer, methoxy polydimethyl methoxy oxyalkylamine / fluorene copolymer, methoxy PEG-114 /polyε-caprolactone, myristic acid/palmitic acid/stearic acid/capric acid/eicosan diglyceride, octyl acrylamide/acrylate/butyl methacrylate copolymer , PEG-800/polyvinyl alcohol copolymer, PEG/PPG-25/25 polydimethyloxy oxyalkylamine/acrylate copolymer, PEG-8/SMDI copolymer, polypropylene decylamine, polypropylene Ester-6, polyacrylate-8, polyacrylate-9, polyacrylate-15, polyacrylate-16, polyacrylate-17, polyacrylate-18, polyacrylate-19, poly-β-aniline /glutaric acid crosslinked polymer, polybutylene terephthalate, polyester-1, polyethyl acrylate, polyethylene terephthalate, polyimide-1, polymethacryl fluorenyl Ethyl betaine, polypentaerythritol terephthalate, polyperfluoroperhydrophenanthrene, polyquaternium-4/hydroxypropyl starch copolymer, polyurethane-1, polyurethane -6, Polycarbamate-10, Polyurethane-18, Polyurethane-19, Polyvinyl Acetate, Polyvinyl Butyral, Polyvinylcaprolamine, Poly Vinyl methamine, polyvinylimidazolium acetate, polyvinyl methyl ether, PVM Butyl ester potassium salt/MA copolymer, PVM ethyl ester potassium salt/MA copolymer, PPG-70 polyglyceryl-10 ether, PPG-12/SMDI copolymer, PPG-51/SMDI copolymer, PVM/ MA copolymer, PVP/VA/itaconic acid copolymer, PVP/VA/vinyl propionate copolymer, rhizobial gum, rosin acrylate, shellac, decyl quaternary ammonium-16/glycidoxy dimethyl methacrylate Cross-linked oxyalkylene polymer, butyl acrylate sodium salt/MA copolymer of PVM, ethyl ester sodium salt/MA copolymer of PVM, sodium polyacrylate, sodium poly-γ-aminoglutarate, soybean protein Acid ester, sterculia urens gum, terephthalic acid/isophthalic acid/sodium isophthalate/ethylene glycol copolymer, dimethylolpropane triacrylate, trimethyl oxime Based on alkylaminopyristyl pullulan, VA/crotonate copolymer, VA/crotonate/methacryloxybenzophenone-1 copolymer, VA/crotonate/ Neodecanoic acid vinyl ester copolymer, VA/crotonate/vinyl propionate copolymer, VA/DBM copolymer, VA/vinyl benzoate/crotonate copolymer, vinylamine/vinyl alcohol copolymer, Vinyl caprolactam / VP / A Dimethylamine ethyl acrylate copolymer, VP/acrylate/lauryl methacrylate copolymer, VP/dimethylaminoethyl methacrylate copolymer, VP/DMAPA acrylate copolymer, VP/ Hexadecene copolymer, VP/methacrylamide/vinylimidazole copolymer, VP/VA copolymer, VP/vinyl caprolactam/DMAPA acrylate copolymer, yeast palmitate, such as phenylpropyl a ruthenium-based polymer or resin such as dimethyl methoxy phthalate, trimethyl decyl decanoate, cyclopentaoxane, trimethyl decyl phthalate, diisostearyl Mercapto trimethylolpropane decyloxydecanoate, vinyl polydimethyloxane crosspolymer/blend and alkyl cetyl alkyl poly Methyl decane cross-linking polymer.
在一個具體例中,該泡沫安定劑包括以註冊名稱Aquaflex SF-40販售的VP/乙烯己內醯胺/二甲胺基丙基甲基丙烯醯胺共聚物或以註冊名稱Aquaflex XL-30販售的異丁烯/二甲胺基丙基順丁烯二醯亞胺/乙氧基化順丁烯二醯亞胺/順丁烯二酸共聚物。 In one embodiment, the foam stabilizer comprises a VP/ethylene caprolactam/dimethylaminopropyl methacrylamide copolymer sold under the registered name Aquaflex SF-40 or under the registered name Aquaflex XL-30 Isobutylene/dimethylaminopropyl maleimide/ethoxylated maleimide/maleic acid copolymer sold.
在一個具體例中,泡沫安定劑係以約0.005至約4重量百分比活性的量存在,以該含醇組成物的總重量為基準。在另一個具體例中,該泡沫安定劑係以約0.01至約1重量百分比活性的量存在,以該含醇組成物的總重量為基準,且在又另一個具體例中,該泡沫安定劑係以約0.02至約0.2重量百分比活性的量存在,以該含醇組成物的總重量為基準。 In one embodiment, the foam stabilizer is present in an amount from about 0.005 to about 4 weight percent active, based on the total weight of the alcohol-containing composition. In another embodiment, the foam stabilizer is present in an amount from about 0.01 to about 1 weight percent active, based on the total weight of the alcohol-containing composition, and in yet another embodiment, the foam stabilizer It is present in an amount of from about 0.02 to about 0.2 weight percent active, based on the total weight of the alcohol-containing composition.
在一個具體例中,將該泡沫安定劑直接加至該含醇組成物。在一或更多個具體例中,將該泡沫安定劑以溶液或乳液形式加至該含醇組成物。換句話說,該泡沫安定劑可與載劑預混合而形成泡沫安定劑溶液或乳液,附帶條件為該載劑不會不利地影響該含醇組成物的性質。載劑的例子包括水、醇、例如丙二醇或乙二醇等的二醇類、酮類、線性及/或環狀烴類、三酸甘油脂類、碳酸酯類、矽氧類、烯類、例如醋酸酯等的酯類、苯甲酸酯類、脂肪酯類、甘油酯類、醚類、醯胺類、聚乙二醇類及PEG/PPG共聚物類、例如生理食鹽水等的無機鹽溶液及其混合物。要了解的是,當該泡沫安定劑預混合而形成泡沫安定劑溶液或乳 液時,加至該含醇組成物的溶液或乳液量係經選擇使泡沫安定劑的量落在上述範圍內。 In one embodiment, the foam stabilizer is added directly to the alcohol-containing composition. In one or more specific examples, the foam stabilizer is added to the alcohol-containing composition in the form of a solution or emulsion. In other words, the foam stabilizer can be premixed with the carrier to form a foam stabilizer solution or emulsion, with the proviso that the carrier does not adversely affect the properties of the alcohol-containing composition. Examples of the carrier include water, alcohols, glycols such as propylene glycol or ethylene glycol, ketones, linear and/or cyclic hydrocarbons, triglycerides, carbonates, oximes, alkenes, For example, esters such as acetate, benzoates, fatty esters, glycerides, ethers, guanamines, polyethylene glycols, and PEG/PPG copolymers, for example, inorganic salt solutions such as physiological saline. And mixtures thereof. It is to be understood that when the foam stabilizer is premixed to form a foam stabilizer solution or milk In the case of a liquid, the amount of the solution or emulsion added to the alcohol-containing composition is selected such that the amount of the foam stabilizer falls within the above range.
在一個具體例中,發泡表面活性劑對泡沫安定劑的重量比為約3.5:1至約14.5:1,且在另一個具體例中,發泡表面活性劑對泡沫安定劑的重量比為約8:1至約11:1。 In one embodiment, the weight ratio of foaming surfactant to foam stabilizer is from about 3.5:1 to about 14.5:1, and in another embodiment, the weight ratio of foaming surfactant to foam stabilizer is About 8:1 to about 11:1.
在一些具體例中,該泡沫安定劑將提高泡沫安定性,即泡沫破掉變成液體耗費的時間長度。特別是,已發現當該發泡表面活性劑包含氟表面活性劑時,泡沫安定劑的存在將改善泡沫的安定性。當該發泡表面活性劑包含矽氧烷聚合物時,該泡沫安定劑係選擇性的。 In some embodiments, the foam stabilizer will increase foam stability, i.e., the length of time it takes for the foam to break into liquid. In particular, it has been found that when the foaming surfactant comprises a fluorosurfactant, the presence of the foam stabilizer will improve the stability of the foam. When the foaming surfactant comprises a siloxane polymer, the foam stabilizer is selective.
該泡沫安定劑可以許多方式操作以改善泡沫的安定性。在一或更多個具體例中,該泡沫安定劑也將改善泡沫品質,即提高氣泡數數及/或降低氣泡尺寸。 The foam stabilizer can be manipulated in a number of ways to improve the stability of the foam. In one or more embodiments, the foam stabilizer will also improve the quality of the foam, i.e., increase the number of bubbles and/or reduce the size of the bubbles.
現在對照圖式,第1A圖顯示泡沫剛分配之後,右邊有經安定化的發泡組成物且左邊有未經安定化的發泡組成物之表面的照片。更明確地說,兩種發泡組成物含有相同量的乙醇、氟表面活性劑、保濕劑及水。右邊的發泡組成物也含有約0.14重量%的泡沫安定劑。可見到未經安定化的泡沫含有一些小氣泡,但是含有比經安定化的泡沫大量之大的、鬆散的泡沫。 Referring now to the drawings, Figure 1A shows a photograph of the surface of the foamed composition that has been stabilized after the foam has been dispensed, with the stabilized foamed composition on the right side and the unstabilized foamed composition on the left side. More specifically, the two foaming compositions contain the same amount of ethanol, fluorosurfactant, humectant, and water. The foamed composition on the right also contained about 0.14% by weight of a foam stabilizer. It can be seen that the unstabilized foam contains some small bubbles, but contains a large amount of loose foam than the stabilized foam.
第1B圖為顯示泡沫分配1分鐘之後,含有第1A圖的發泡組成物之表面的照片。可見到儘管經安定化的泡沫基本上保持不變,但是該未經安定化的泡沫將變成邊緣四周濕濕的。 Fig. 1B is a photograph showing the surface of the foamed composition of Fig. 1A after 1 minute of foam distribution. It can be seen that although the stabilized foam remains substantially unchanged, the unstabilized foam will become wet around the edges.
第1C圖為顯示泡沫分配3分鐘之後,含有第1A圖的發泡組成物之表面的照片。可見到經安定化的泡沫基本上保持不變,然而該未經安定化的泡沫卻變得很濕。 Fig. 1C is a photograph showing the surface of the foamed composition of Fig. 1A after 3 minutes of foam distribution. It can be seen that the stabilized foam remains substantially unchanged, however the unstabilized foam becomes very wet.
第1D圖為顯示泡沫分配5分鐘之後,含有第1A圖的發泡組成物之表面的照片。可見到經安定化的泡沫基本上保持不變,然而該未經安定化的泡沫卻主要為液態,只剩少數氣泡。 Fig. 1D is a photograph showing the surface of the foamed composition of Fig. 1A after 5 minutes of foam distribution. It can be seen that the stabilized foam remains substantially unchanged, however, the unstabilized foam is mainly liquid, leaving only a few bubbles.
第1E圖為顯示泡沫分配1小時之後,含有第1A圖的發泡組成物之表面的照片。可見到經安定化的泡沫有很多泡沫,但是未經安定化的泡沫卻瓦解成液態。在一個具體例中,當含有大於40重量%醇、氟表面活性劑及泡沫安定劑的組成物在室溫下通過非液化氣體發泡泵時所產生的泡沫安定性大於不包括泡沫安定劑的組成物通過非液化氣體發泡泵時所產生的泡沫安定性。 Fig. 1E is a photograph showing the surface of the foamed composition of Fig. 1A after 1 hour of foam distribution. It can be seen that the stabilized foam has a lot of foam, but the unstabilized foam collapses into a liquid state. In one embodiment, when the composition containing more than 40% by weight of an alcohol, a fluorosurfactant, and a foam stabilizer is passed through a non-liquefied gas foaming pump at room temperature, the foam stability is greater than that of a foam stabilizer not included. The foam stability produced by the composition when it is passed through a non-liquefied gas foaming pump.
在一個具體例中,當本發明的可發泡之含醇組成物在室溫下通過非液化氣體發泡泵時所產生的泡沫安定性為至少約30秒,在另一個具體例中至少約3分鐘,或換句話說,該含醇組成物維持其泡沫形式且不會破裂成液態至少3分鐘。在另一個具體例中,該泡沫安定性為至少約5分鐘,且在又另一個具體例中,該泡沫安定性為至少約15分鐘。在一或更多個具體例中,該泡沫安定性為至少約30分鐘,且在又另一個具體例中,該泡沫安定性為至少約60分鐘。 In one embodiment, when the foamable alcohol-containing composition of the present invention is passed through a non-liquefied gas foaming pump at room temperature, the foam stability is at least about 30 seconds, and in another embodiment at least about For 3 minutes, or in other words, the alcohol-containing composition maintains its foam form and does not break into a liquid state for at least 3 minutes. In another embodiment, the foam stability is at least about 5 minutes, and in yet another embodiment, the foam stability is at least about 15 minutes. In one or more specific examples, the foam stability is at least about 30 minutes, and in yet another embodiment, the foam stability is at least about 60 minutes.
本發明的含醇組成物可進一步包括寬廣範圍的選擇性 成分,附帶條件為彼等不會不利地影響該含醇組成物的泡沫成形性,或該泡沫安定性。CTFA國際化粧品成分辭典及參考書,第11版,2005年,及2004年CTFA國際採購指南,二者皆以參考的方式將其全文併入此,描敘當用於護膚產業的各種不同非限制化粧品及醫藥成分,彼等都適用於本發明的組成物。這些參考例中有描敘成分的功能分類非限定例子。這些功能分類的例子包括:研磨料、抗痘劑、防結塊劑、抗氧化劑、黏合劑、生物添加物、膨鬆劑、螯合劑、化學添加物、著色劑、美容用收歛劑、美容用生物殺滅劑、變性劑、藥品收歛劑、乳化劑、外用止痛藥、成膜劑、香精成分、保濕劑、遮光劑、可塑劑、防腐劑、推進劑、還原劑、皮膚漂白劑、潤膚劑(柔軟劑、保濕劑,混雜性及非閉塞性)、護膚劑、溶劑、增泡劑、水溶助長劑、溶解劑、懸浮劑(非表面活性劑)、防曬劑、紫外線吸收劑、防黏劑及增黏劑(水性及非水性)。普通熟習此技藝者眾所周知之有用於此的其他材料功能分類的例子包括溶解劑、隔離劑及角質層分離劑等。在一個具體例中,該含醇組成物進一步包含甘油。 The alcohol-containing composition of the present invention may further comprise a wide range of selectivities The ingredients, with the proviso that they do not adversely affect the foam formability of the alcohol-containing composition, or the foam stability. CTFA International Cosmetic Ingredient Dictionary and Reference, 11th Edition, 2005, and 2004 CTFA International Procurement Guidelines, both of which are incorporated by reference in their entirety, describing various unrestricted uses in the skin care industry. Cosmetics and pharmaceutical ingredients, all of which are suitable for use in the compositions of the present invention. Non-limiting examples of functional classification of the described components are included in these reference examples. Examples of these functional classifications include: abrasives, anti-acne agents, anti-caking agents, antioxidants, binders, biological additives, leavening agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic products Biocides, denaturants, drug astringents, emulsifiers, topical analgesics, film formers, perfume ingredients, moisturizers, sunscreens, plasticizers, preservatives, propellants, reducing agents, skin bleaches, emollients Agent (softener, moisturizer, mixed and non-occlusive), skin care agent, solvent, foam booster, hydrotrope, solubilizer, suspending agent (non-surfactant), sunscreen, UV absorber, anti-adhesive Agents and tackifiers (aqueous and non-aqueous). Examples of other material functional classifications well known to those skilled in the art that are useful herein include solubilizers, release agents, and keratolytic agents. In one embodiment, the alcohol-containing composition further comprises glycerin.
該含醇組成物中可包括輔助表面活性劑,以達增加或改變泡沫品質及特性的目的,改變擦拭及/或乾燥時最終配方的質感,提供醇的持續或長效微生物作用,溶解例如香精或防曬劑等其他成分,及緩和刺激。輔助表面活性劑包括,但不一定限於,硫代丁二酸酯、氧化胺、PEG-80山梨醇月桂酸酯、聚葡糖苷、烷醇醯胺、山梨醇衍生物、 脂肪醇乙氧基化物、四級銨化合物、醯胺基胺、磺酸甜菜鹼、異硫代羥酸、肌氨酸、甜菜鹼及脂肪醇聚乙二醇。 A co-surfactant may be included in the alcohol-containing composition for the purpose of increasing or changing the quality and characteristics of the foam, changing the texture of the final formulation upon wiping and/or drying, providing sustained or long-acting microbial action of the alcohol, dissolving, for example, flavors Or other ingredients such as sunscreens, and to ease the irritation. Co-surfactants include, but are not necessarily limited to, thiosuccinate, amine oxide, PEG-80 sorbitol laurate, polyglucoside, alkanolamine, sorbitol derivatives, Fatty alcohol ethoxylates, quaternary ammonium compounds, guanamine amines, sulfobetaines, isothiohydroxy acids, sarcosine, betaines and fatty alcohol polyethylene glycols.
儘管推進劑可用於產生安定的泡沫,但是不一定需要推進劑。有些具體例中,推進劑的量少於以重量計約每百萬份1000份,以此含醇組成物的總重量為基準。在一個具體例中,該含醇組成物實質上不含推進劑,例如烴推進劑。實質上不含意指在含醇組成物中的推進劑量少於以重量計約每百萬份100份,以此含醇組成物的總重量為基準。 Although propellants can be used to create a stable foam, propellants are not necessarily required. In some embodiments, the amount of propellant is less than about 1000 parts per million by weight based on the total weight of the alcohol-containing composition. In one embodiment, the alcohol-containing composition is substantially free of propellant, such as a hydrocarbon propellant. Substantially free means that the propellant dose in the alcohol-containing composition is less than about 100 parts per million by weight based on the total weight of the alcohol-containing composition.
在一個具體例中,醇係被加入該組成物的唯一活性抗微生物成分,且在此具體例中輔助抗微生物成分少於約0.1重量百分比,以此含醇組成物的總重量為基準。在其他具體例中,該組成物除了醇以外包括輔助抗微生物劑。輔助抗微生物劑包括,但不限於,三氯沙(triclosan),亦稱為5-氯-2-(2,4-二氯苯氧基)酚且可以註冊名稱IRGASAN®自Ciba-Geigy有限公司購得;氯二甲苯酚,亦稱為4-氯-3,5-二甲基酚且可以註冊名稱NIPACIDE® MX或PX自Nipa Laboratories股份有限公司購得;合克替啶(hexetidine),亦稱為5-胺基-1,3-雙(2-乙基己基)-5-甲基六氫嘧啶;氯己定(chlorhexidine)鹽,包括氯己定葡萄糖酸鹽及N,N”-雙(4-氯苯基)-3,12-二亞胺基-2,4,11,14-四氮十四烷二亞胺醯胺;2-溴-2-硝丙烷-1;3-二醇,苯扎氯銨(benzalkonium chloride);西吡氯銨(cetylpyridinium chloride);烷基二甲基芐基氯化銨; 碘;酚衍生物,吡咯烷酮碘包括聚乙烯吡咯烷酮碘;對羥基苯甲酸酯;乙內醯脲及其衍生物,包括2,4-咪唑啉二酮及2,4-咪唑啉二酮的衍生物及二羥甲基-5,5-二甲基乙內醯脲(亦稱為DMDM乙內醯脲或增效廣譜防腐劑(glydant));苯氧基乙醇;氯化1-(3-氯烯丙基)-3,5,6-三氮雜-1-氮鎓金剛烷的順式異構物,亦稱為季銨鹽-15且以註冊名稱DOWCILTM 2000自Dow Chemical公司購得;重氮烷基咪唑脲、氯化苯銨松寧(benzethonium chloride);甲基氯化苯銨松寧;及其混合物。使用時,該輔助抗微生物劑存在約0.1至約1重量%的量,以此含醇組成物的總重量為基準。 In one embodiment, the alcohol is added to the sole active antimicrobial component of the composition, and in this particular embodiment the auxiliary antimicrobial component is less than about 0.1 weight percent based on the total weight of the alcohol-containing composition. In other embodiments, the composition includes an auxiliary antimicrobial agent in addition to the alcohol. Auxiliary antimicrobial agents include, but are not limited to, triclosan (Triclosan), also known as 5-chloro-2- (2,4-dichlorophenoxy) phenol and may be registered name IRGASAN ® from Ciba-Geigy Co. Chloroxylenol, also known as 4-chloro-3,5-dimethylphenol, is available under the registered name NIPACIDE® MX or PX from Nipa Laboratories, Inc.; hexetidine, also Known as 5-amino-1,3-bis(2-ethylhexyl)-5-methylhexahydropyrimidine; chlorhexidine salt, including chlorhexidine gluconate and N,N"-double (4-chlorophenyl)-3,12-diimido-2,4,11,14-tetraazatetradecanediimine decylamine; 2-bromo-2-nitropropane-1; 3-di Alcohol, benzalkonium chloride; cetylpyridinium chloride; alkyl dimethyl benzyl ammonium chloride; iodine; phenol derivative, pyrrolidone iodine including polyvinylpyrrolidone iodine; p-hydroxybenzoic acid Ester; carbendazim and its derivatives, including derivatives of 2,4-imidazolidinone and 2,4-imidazolidinone and dimethylol-5,5-dimethylhydantoin ( Also known as DMDM intramethylene urea or a synergistic broad-spectrum preservative (glydant); phenoxyethanol; Of 1- (3-chloroallyl) -3,5,6-triaza-l-azoniaadamantane cis isomer, also known as quaternium-15 and the registered name DOWCIL TM 2000 Available from Dow Chemical; diazolidinium imidazolium, benzethonium chloride; methylammonium chloride, and mixtures thereof. When used, the co-improving agent is present at about 0.1 to An amount of about 1% by weight based on the total weight of the alcohol-containing composition.
本發明的含醇組成物可視需要進一步包含各種不同的局部藥物活性成分,附帶條件為彼等不會不利地影響該含醇組成物的泡沫形成性質,或泡沫安定性。局部藥物活性成分的例子包括水楊酸、乙醯基水楊酸、順式維生素甲酸、反式維生素甲酸、N-乙醯基-L-光胱胺酸、硫辛酸、壬二酸、植酸、溶菌磷酯酸(lisophosphotidic acid)、四環素、異丁苯乙酸(ibuprofen)、拿百疼(naproxen)、對乙醯胺基酚(acetominophen)、氫皮質酮(hydrocortisone)、間苯二酚、苯氧基乙醇、苯氧基丙醇、苯氧基異丙醇、2,4,4’-二氯-2’-羥基二苯基醚、3,4,4’-三氯對稱二苯脲、吡啶酮乙醇胺(octopirox)、2-苯基苯并咪唑-5-磺酸、二羥丙酮、過氧化苯甲醯、2,4,4’-三氯-2-羥基二苯基醚、苯氧基乙醇、苯氧基丙醇、苯氧 基異丙醇、植酸、硫辛酸、溶菌磷酯酸、苯噁洛芬(benoxaprofen)、氟比洛芬(flubiprofen)、非洛布洛芬(fenoprofen)、芬布芬(fenbufen)、酮洛芬(ketoprofen)、吲哚洛芬(indoprofen)、布洛芬(priprofen)、卡洛芬(carpofen)、奧沙普秦(oxaprozin)、普拉洛芬(pranoprofen)、咪洛芬(miroprofen)、硫噁洛芬(tioxaprofen)、舒洛芬(suprofen)、阿明洛芬(alminoprofen)、噻洛芬酸(tiaprofenic acid)、氟洛芬(fluprofen)、布氯酸(bucloxic acid)、苯唑卡因(benzocaine)、利多卡因(lidocaine)、布比卡因(bupivacaine)、氯普魯卡因(chloroprocaine)、地佈卡因(dibucaine)、依替卡因(etidocaine)、甲哌卡因(mepivacaine)、丁卡因(tetracaine)、達克羅寧(dyclonine)、海克卡因(hexylcaine)、普魯卡因(procaine)、古柯鹼(cocaine)、氯胺酮(ketamine)、普拉莫卡因(pramoxine)、酚、二羥基丙酮、酪氨酸、酪氨酸乙酯、磷-DOPA、β-內醯亞胺藥物、喹啉藥物、環丙沙星(ciprofloxacin)、蒽諾沙星(nrofloxacin)、紅黴素(erythromycin)、阿米卡星(amikacin)、去氧羥四環素(doxycycline)、捲曲黴素(capreomycin)、氯苯胍亭(chlorhexidine)、金黴素(chlortetracycline)、土黴素(oxytetracycline)、克林黴素(clindamycin)、乙胺丁醇、羥乙磺酸脒定(hexamidinee isethionate)、甲硝唑 (metronidazole)、噴他脒(pentamidine)、慶大霉素(gentamicin)、卡那黴素(kanamycin)、林可黴素(lineomycin)、甲烯土黴素(methacycline)、六亞甲四胺(methenamine)、米諾環素(minocycine)、新黴素(neomycin)、乙基西梭黴素(netilmicin)、巴母黴素(paromomycin)、鏈黴素(streptomycin)、妥布黴素(tobramycin)、咪康唑(miconazole)、鹽酸四環素、紅黴素(erythromycin)、鋅紅黴素、依托紅黴素(erythromycin estolate)、硬脂酸紅黴素、硫酸阿米卡星、鹽酸去氧羥四環素、硫酸捲曲黴素、葡萄糖醛酸氯己定、鹽酸氯己定、鹽酸金黴素、鹽酸土黴素、鹽酸克林黴素、鹽酸乙胺丁醇、鹽酸甲硝唑、鹽酸噴他脒、硫酸慶大霉素、硫酸卡那黴素、鹽酸林可黴素、鹽酸甲烯土黴素、馬脲酸烏洛托品(methenamine hippurate)、扁桃酸烏洛托品(methenamine mandelate)、鹽酸米諾環素(minocycline hydrochloride)、硫酸新黴素、硫酸乙基西梭黴素、硫酸巴母黴素、硫酸鏈黴素、硫酸妥布黴素、鹽酸咪康唑、鹽酸阿曼華定(amanfadine hydrochloride)、硫酸阿曼華定、吡啶酮乙醇胺、對二氯間二甲酚、制黴菌素(nystatin)、托萘酯(tolnaftate)、克霉唑(clotrimazole)、對-甲氧基肉桂酸-2-乙基己酯、對-胺基苯甲酸酯、對-胺基苯甲酸、2-苯基苯并咪唑-5-磺酸、奧克立林(octocrylene)、2-羥基-4-甲氧基-苯甲酮(oxybenzone)、水楊酸高钣酯、水楊酸辛酯、4,4’-甲氧 基-第三丁基二苯甲醯基甲烷、4-異丙基二苯甲醯基甲烷、3-亞苯基莰酮、3-(4-甲基亞苯基)莰酮、二氧化鈦、氧化矽、氧化鐵、2,4-二羥苯甲酮的4-N,N-(2-乙基己基)甲基胺苯甲酸酯、含4-羥基二苯甲醯基甲烷的4-N,N-(2-乙基己基)甲基胺苯甲酸酯、2-羥基-4-(2-羥乙氧基)苯甲酮的4-N,N-(2-乙基己基)甲基胺苯甲酸酯、4-(2-羥乙氧基)二苯甲醯基甲烷的4-N,N-(2-乙基己基)甲基胺苯甲酸酯、四環素、異丁苯乙酸、拿百疼、對乙醯胺基酚、間苯二酚、3,4,4’-三氯對稱二苯脲、吡啶酮乙醇胺、上述之醫藥上可接受的鹽及混合物。 The alcohol-containing composition of the present invention may further comprise various different topical pharmaceutically active ingredients as needed, provided that they do not adversely affect the foam forming properties of the alcohol-containing composition, or foam stability. Examples of topical pharmaceutically active ingredients include salicylic acid, acetylsalicylic acid, cis-vitaminic acid, trans-vitaminic acid, N-ethyl decyl-L-photocysteine, lipoic acid, azelaic acid, phytic acid , lisophosphotidic acid, tetracycline, ibuprofen, naproxen, acetominophen, hydrocortisone, resorcinol, benzene Oxyethanol, phenoxypropanol, phenoxyisopropanol, 2,4,4'-dichloro-2'-hydroxydiphenyl ether, 3,4,4'-trichloro symmetrical diphenylurea, Octopyrox, 2-phenylbenzimidazole-5-sulfonic acid, dihydroxyacetone, benzammonium peroxide, 2,4,4'-trichloro-2-hydroxydiphenyl ether, phenoxy Ethanol, phenoxypropanol, phenoxy Isopropanol, phytic acid, lipoic acid, lysophosphatidic acid, benoxaprofen, flurbiprofen, fenoprofen, fenbufen, ketopro Ketoprofen, indoprofen, priprofen, caroffen, oxaprozin, pranoprofen, miroprofen, Tioxaprofen, suprofen, alminoprofen, tiaprofenic acid, fluprofen, bucloxic acid, benzocaine ( Benzocaine), lidocaine, bupivacaine, chloroprocaine, dibucaine, etidocaine, mepivacaine , tetracaine, dyclonine, hexylcaine, procaine, cocaine, ketamine, pramocaine Pramoxine), phenol, dihydroxyacetone, tyrosine, tyrosine ethyl ester, phosphorus-DOPA, β-indoline drug, quinoline drug, ciprofloxacin , nrofloxacin, erythromycin, amikacin, doxycycline, capreomycin, chlorhexidine, chlortetracycline (chlortetracycline), oxytetracycline, clindamycin, ethambutol, hexamidinee isethionate, metronidazole (metronidazole), pentamidine, gentamicin, kanamycin, lineomycin, methacycline, hexamethylenetetramine ( Methenamine), minocycine, neomycin, netilmicin, paromomycin, streptomycin, tobramycin , miconazole, tetracycline hydrochloride, erythromycin, erythromycin, erythromycin estolate, erythromycin stearate, amikacin sulfate, deoxytetracycline hydrochloride , capreomycin sulfate, chlorhexidine glucuronide, chlorhexidine hydrochloride, chlortetracycline hydrochloride, oxytetracycline hydrochloride, clindamycin hydrochloride, ethambutol hydrochloride, metronidazole hydrochloride, pentamidine hydrochloride, Gentamicin sulfate, kanamycin sulfate, lincomycin hydrochloride, methotrexate hydrochloride, methenamine hippurate, methotamine mandelate, hydrochloric acid rice Nincycline hydrochloride, neomycin sulfate, ethyl cilostatin sulfate, sulfur Mycomycin, streptomycin sulfate, tobramycin sulfate, miconazole hydrochloride, amanfadine hydrochloride, omanvadine sulfate, pyridoneethanolamine, p-dichloro-xylenol, nystatin (nystatin), tolnaftate, clumprimazole, p-methoxycinnamic acid 2-ethylhexyl ester, p-aminobenzoic acid ester, p-aminobenzoic acid, 2 -Phenylbenzimidazole-5-sulfonic acid, octocrylene, 2-hydroxy-4-methoxy-benzophenone, valproate salicylate, octyl salicylate, 4 , 4'-methoxy -T-butyldibenylmethane, 4-isopropyldibenylmethane, 3-phenylene fluorenone, 3-(4-methylphenylene)fluorenone, titanium dioxide, oxidation 4-N,N-(2-ethylhexyl)methylamine benzoate of hydrazine, iron oxide, 2,4-dihydroxybenzophenone, 4-N containing 4-hydroxybenzhydrylmethane , N-(2-ethylhexyl)methylamine benzoate, 4-N,N-(2-ethylhexyl)methyl 2-hydroxy-4-(2-hydroxyethoxy)benzophenone 4-N,N-(2-ethylhexyl)methylamine benzoate, tetracycline, isobutylbenzene, 4-aminocarbonyl benzoate, 4-(2-hydroxyethoxy)dibenzoylmethane Acetic acid, acesulfame, p-acetaminophen, resorcinol, 3,4,4'-trichloro symmetrical diphenylurea, pyridoneethanolamine, pharmaceutically acceptable salts and mixtures thereof.
在一個具體例中,該含醇組成物的餘量包括水或其他適合溶劑。在一個具體例中,該配方中包括一或更多種揮發性矽氧為底的材料以進一步輔助蒸發製程。例示性揮發矽氧具有比醇低的蒸發熱。在一個具體例中,使用矽氧為底的材料可降低流動組成物的表面張力。在一個具體例中,配方中可包括約4重量%至約50重量%濃度之矽氧為底的材料,例如環甲基矽氧烷、三甲基矽氧基矽酸酯或其組合,且在另一個具體例中約5重量%至約35重量%,以此含醇組成物的總重量為基準。 In one embodiment, the balance of the alcohol-containing composition includes water or other suitable solvent. In one embodiment, the formulation includes one or more volatile oxygen-based materials to further assist in the evaporation process. Exemplary volatile helium oxygen has a lower heat of vaporization than alcohol. In one embodiment, the use of a helium oxygen-based material reduces the surface tension of the flowing composition. In one embodiment, the formulation may include from about 4% to about 50% by weight of a concentration of the oxygen-based material, such as cyclomethoxane, trimethyldecyloxydecanoate, or combinations thereof, and In another embodiment, from about 5% by weight to about 35% by weight, based on the total weight of the alcohol-containing composition.
在一個具體例中,例如上述沖洗配方,此含醇組成物的餘量包括發泡表面活性劑。 In one embodiment, such as the rinse formulation described above, the balance of the alcohol-containing composition includes a lathering surfactant.
該含醇組成物可將成分簡單混合在一起而製備。添加順序沒有特別限制。在一個具體例中,皮膚消毒性含醇組成物係藉由包含將發泡表面活性劑緩慢地分散在醇中以緩 和攪動,添加水,接著添加泡沫安定劑,及混合直到混合物均勻為止而製備。 The alcohol-containing composition can be prepared by simply mixing the ingredients together. The order of addition is not particularly limited. In one embodiment, the skin-disinfecting alcohol-containing composition is slowed by comprising slowly dispersing the foaming surfactant in the alcohol. And agitating, adding water, then adding a foam stabilizer, and mixing until the mixture is homogeneous.
本發明的可發泡之組成物可以通常用於泡沫產物之任何類型的分散器來運用。有利地,儘管可發泡之組成物可視需要藉由將該組成物霧狀化而發泡,霧狀化產物不需要發泡。可混合該可發泡之含醇組成物與空氣或鈍性氣體的分散器都可使用。鈍性氣體包括實質上不會反應或不利地影響該可發泡的組成物之氣體。鈍性氣體的例子包括氮、氬、氙、氪、氦、氖及氡。在一個具體例中,該含醇組成物係用於使用發泡泵的分散器,其在混合室中結合周遭空氣或鈍性氣體及含醇組成物並使該混合物通過篩網。在各種不同的具體例中,該組成物的黏度係低於約100毫帕,在一個具體例中低於約50毫帕,且在另一個具體例中低於約25毫帕。 The foamable composition of the present invention can be utilized in any type of disperser commonly used in foam products. Advantageously, the aerosolized product does not require foaming, although the foamable composition can be foamed by atomizing the composition as desired. A disperser that can mix the foamable alcohol-containing composition with air or a passive gas can be used. A passive gas includes a gas that does not substantially react or adversely affect the foamable composition. Examples of the passive gas include nitrogen, argon, helium, neon, krypton, xenon, and krypton. In one embodiment, the alcohol-containing composition is used in a disperser using a foaming pump that combines ambient air or a passive gas and an alcohol-containing composition in a mixing chamber and passes the mixture through a screen. In various embodiments, the composition has a viscosity of less than about 100 millipascals, in one embodiment less than about 50 millipascals, and in another embodiment less than about 25 millipascals.
本發明的含醇組成物將產生經安定化的泡沫。結果,該發泡組成物較不會破掉變成液態且從發泡泵及/或相關分散器元件滴落。 The alcohol-containing composition of the present invention will produce a stabilized foam. As a result, the foamed composition does not break into a liquid state and drip from the foaming pump and/or the associated disperser element.
因此,本發明進一步提供降低組成物從發泡泵滴落的方法。藉由使用可發泡泵而分散可發泡之組成物時,一部分分散的組成物,現在呈泡沫狀,將留在分散器頭部中直到另一份分散為止。若該分散器頭部中的泡沫將在分散器使用之間破掉變成液態,該液體將從該分配器頭部滴落。該分配器使用之間的時間一般可標示成X分鐘。「X」可廣闊地變動。 Accordingly, the present invention further provides a method of reducing the dripping of a composition from a foaming pump. When the foamable composition is dispersed by using a foamable pump, a portion of the dispersed composition, now in the form of a foam, will remain in the head of the disperser until another portion is dispersed. If the foam in the head of the disperser will break into a liquid state between the use of the disperser, the liquid will drip from the head of the dispenser. The time between use of the dispenser can generally be indicated as X minutes. "X" can vary widely.
有利地,當X為約3分鐘或更短時本發明之經安定化的泡沫不會從該分配器滴落。在一個具體例中,當X為約5分鐘或更短時經安定化的泡沫不會從該分配器滴落,且在另一個具體例中,X為約15分鐘或更短。在一或更多個具體例中,當X為約30分鐘或更短時經安定化的泡沫不會從該分配器滴落,且在其他具體例中,當X為約60分鐘或更短時經安定化的泡沫不會從該分配器滴落。 Advantageously, the stabilized foam of the present invention does not drip from the dispenser when X is about 3 minutes or less. In one embodiment, the stabilized foam does not drip from the dispenser when X is about 5 minutes or less, and in another embodiment, X is about 15 minutes or less. In one or more specific examples, the stabilized foam does not drip from the dispenser when X is about 30 minutes or less, and in other embodiments, when X is about 60 minutes or less. The stabilized foam does not drip from the dispenser.
為了說明本發明的實施方式,在下列實施例中製備且試驗。然而,該等實施例應不得視為限制本發明的範圍。該等申請專利範圍將用於界定本發明。 In order to illustrate the embodiments of the present invention, they were prepared and tested in the following examples. However, the examples should not be construed as limiting the scope of the invention. The scope of these patent applications will be used to define the invention.
實施例1係藉由緩慢將氟表面活性劑,DEA-C8-18全氟烷基醚磷酸酯,分散在乙醇中以緩和攪動至達到均勻分散為止而製備。接下來,添加保濕劑且混合到該混合物均勻為止。配合混合,添加水。攪動該溶液直到達到均勻的混合物為止。 Example 1 was prepared by slowly dispersing a fluorosurfactant, DEA-C8-18 perfluoroalkyl ether phosphate, in ethanol to moderate agitation until uniform dispersion was achieved. Next, a humectant is added and mixed until the mixture is homogeneous. Mix with water and add water. The solution was agitated until a homogeneous mixture was reached.
使該可發泡之混合物通過Airspray®發泡泵。依下文所述的方式提昇泡沫的品質及安定性,且將結果總結在表2中。 The foamable mixture was passed through an Airspray® foam pump. The quality and stability of the foam were improved in the manner described below and the results are summarized in Table 2.
使用簡單的1至5級系統來評估各系統的泡沫,而5為最佳。 A simple 1 to 5 system was used to evaluate the foam of each system, while 5 was the best.
泡沫品質評分級數:品質為由典型市售發泡泵來分散時分散泡沫可見到的外觀之量測。 Foam quality rating series: The quality is the measure of the appearance of the dispersed foam as it is dispersed by a typical commercial foam pump.
級數0至5 Series 0 to 5
0無泡沫 0 no foam
1濕濕的,有大又鬆散的氣泡之易破泡沫 1 wet and wet foam with large and loose bubbles
2大又鬆散的氣泡,有些小氣泡 2 large and loose bubbles, some small bubbles
3泡沫約等量的小及大氣泡 3 foam is about the same amount of small and large bubbles
4泡沫主要具有小又密的氣泡 4 foam mainly has small and dense bubbles
5具有小又密的氣泡之柔順又緻密的泡沫 5 a soft and dense foam with small, dense bubbles
泡沫安定性評分級數:藉由測量泡沫破掉變成液體耗費的時間來評估安定性。不良安定性評分與從牆壁檯面上的分散器滴落有關。3或更高的分數顯示醇泡沫的安定化相當好。 Foam Stability Rating Series: The stability is assessed by measuring the time it takes for the foam to break into liquid. The poor stability score is related to dripping from the diffuser on the wall countertop. A score of 3 or higher indicates that the stability of the alcohol foam is quite good.
級數0至5 Series 0 to 5
0立即融化(<30秒) 0 melt immediately (<30 seconds)
1約30至60秒融化 1 about 30 to 60 seconds to melt
2約1至15分鐘融化 2 about 1 to 15 minutes of melting
3約15至30分鐘融化 3 about 15 to 30 minutes to melt
4約30至60分鐘融化 4 about 30 to 60 minutes to melt
5約60分鐘之後泡沫還在 5 after about 60 minutes, the bubble is still
實施例2如實施例1所述的方式製備,除了在水之後添加聚季銨鹽-11。使發泡混合物通過發泡泵且依實施例1的方式評估。結果總結於表2中。措辭「qs」表示加足量至總共100個百分比。 Example 2 was prepared as described in Example 1, except that Polyquaternium-11 was added after water. The foaming mixture was passed through a foaming pump and evaluated in the manner of Example 1. The results are summarized in Table 2. The wording "qs" means adding up to a total of 100 percentage points.
製備實施例3至7,發泡且依實施例1及2所述的方式評估,除了量如表2所示般變動。 Examples 3 to 7 were prepared, foamed and evaluated in the manner described in Examples 1 and 2 except that the amounts were varied as shown in Table 2.
以實施例2所述的方式製備實施例8至11,除了在實施例8、9及11中,藉由其他聚合物代替聚季銨鹽-11。使各可發泡的混合物通過發泡泵且以實施例1的方式評估。結果總結在表3中。 Examples 8 to 11 were prepared in the manner described in Example 2 except that in Examples 8, 9, and 11, the polyquaternium-11 was replaced by another polymer. Each foamable mixture was passed through a foaming pump and evaluated in the manner of Example 1. The results are summarized in Table 3.
以實施例1所述的方式製備實施例12至24,除了氟表面活性劑的量變動,且外加或代替實施例1的氟表面活性劑使用兩種發泡表面活性劑,全氟壬基乙基羧基癸基PEG10二甲基矽氧烷及二甲基矽氧烷共聚物十一烯酸酯。實施例10也含有聚季銨鹽-11。使各可發泡的混合物通過發泡泵且以實施例1的方式評估。結果總結在表4及5中。 Examples 12 to 24 were prepared in the manner described in Example 1, except that the amount of the fluorosurfactant was varied, and the fluorosurfactant of Example 1 was used instead of or in place of the two surfactants, perfluorodecyl B. Base carboxy fluorenyl PEG 10 dimethyl methoxy oxane and dimethyl methoxy olefin copolymer undecylenate. Example 10 also contained polyquaternium-11. Each foamable mixture was passed through a foaming pump and evaluated in the manner of Example 1. The results are summarized in Tables 4 and 5.
以實施例2所述的方式製備實施例25至36,除了量如表6及7所示而變動,且在一個實施例中,外加或代替實施例2的氟表面活性劑使用不同發泡表面活性劑。實施例33不含聚季銨鹽-11。結果總結在表6及7中。 Examples 25 to 36 were prepared in the manner described in Example 2 except that the amounts were varied as shown in Tables 6 and 7, and in one embodiment, the fluorosurfactant was used in addition to or in place of Example 2 using different foamed surfaces. Active agent. Example 33 contained no polyquaternium-11. The results are summarized in Tables 6 and 7.
將實施例1之可發泡組成物置於壁式分配器的Airspray®發泡泵中。從該泵分配出一份組成物。3()秒至1分鐘之後,見到液體從分配器頭部滴落。 The embodiments of the foamable composition of Example 1 was placed in a wall dispenser Airspray ® foaming pump. A composition is dispensed from the pump. After 3 () seconds to 1 minute, the liquid was seen to drip from the dispenser head.
對實施例1之可發泡組成物添加0.1重量%聚季銨鹽-11。將此組成物置於壁式分配器的Airspray®發泡泵中。從該泵分配出一份組成物。在約接下來10分鐘的期間,沒見到滴落。 To the foamable composition of Example 1, 0.1% by weight of polyquaternium-11 was added. Airspray ® foam pump of this composition was placed in a wall dispenser. A composition is dispensed from the pump. During the next 10 minutes, no dripping was seen.
不會悖離本發明的範圍及精神之不同修飾及變化對熟於此藝之士而言將變得顯而易見。本發明當然不會受限於在此所述的例示性具體例。 Different modifications and variations will be apparent to those skilled in the art without departing from the scope of the invention. The invention is of course not limited to the illustrative embodiments described herein.
Claims (9)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75453605P | 2005-12-28 | 2005-12-28 | |
| US11/438,664 US20070148101A1 (en) | 2005-12-28 | 2006-05-22 | Foamable alcoholic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201329227A true TW201329227A (en) | 2013-07-16 |
| TWI476278B TWI476278B (en) | 2015-03-11 |
Family
ID=38117633
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095148788A TWI394831B (en) | 2005-12-28 | 2006-12-25 | Foamable alcoholic composition |
| TW102105324A TWI476278B (en) | 2005-12-28 | 2006-12-25 | Foamable alcoholic composition |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095148788A TWI394831B (en) | 2005-12-28 | 2006-12-25 | Foamable alcoholic composition |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20070148101A1 (en) |
| EP (3) | EP2264135A3 (en) |
| JP (1) | JP2007176940A (en) |
| KR (1) | KR101380039B1 (en) |
| CN (2) | CN101003768B (en) |
| AT (1) | ATE439417T1 (en) |
| AU (1) | AU2006252070C1 (en) |
| BR (1) | BRPI0605381A (en) |
| CA (1) | CA2572107C (en) |
| DE (1) | DE602006008411D1 (en) |
| ES (1) | ES2330665T3 (en) |
| MY (1) | MY148766A (en) |
| TW (2) | TWI394831B (en) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6623744B2 (en) * | 1995-06-22 | 2003-09-23 | 3M Innovative Properties Company | Stable hydroalcoholic compositions |
| AU715827B2 (en) * | 1995-06-22 | 2000-02-10 | Minnesota Mining And Manufacturing Company | Stable hydroalcoholic compositions |
| US6582711B1 (en) * | 1997-01-09 | 2003-06-24 | 3M Innovative Properties Company | Hydroalcoholic compositions thickened using polymers |
| WO2005030917A1 (en) * | 2003-09-29 | 2005-04-07 | Ethena Healthcare Inc. | High alcohol content gel-like and foaming compositions |
| DE102004062775A1 (en) | 2004-12-21 | 2006-06-29 | Stockhausen Gmbh | Alcoholic pump foam |
| JP2008531740A (en) * | 2005-03-07 | 2008-08-14 | デブ ワールドワイド ヘルスケア インコーポレーテッド | High alcohol content foamable composition containing a silicone based surfactant |
| US20060204466A1 (en) * | 2005-03-08 | 2006-09-14 | Ecolab Inc. | Hydroalcoholic antimicrobial composition with skin health benefits |
| US7651990B2 (en) * | 2005-06-13 | 2010-01-26 | 3M Innovative Properties Company | Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use |
| US20070185216A1 (en) * | 2006-02-09 | 2007-08-09 | Marcia Snyder | Antiviral method |
| US8450378B2 (en) * | 2006-02-09 | 2013-05-28 | Gojo Industries, Inc. | Antiviral method |
| US8119115B2 (en) | 2006-02-09 | 2012-02-21 | Gojo Industries, Inc. | Antiviral method |
| US9629361B2 (en) | 2006-02-09 | 2017-04-25 | Gojo Industries, Inc. | Composition and method for pre-surgical skin disinfection |
| WO2008067028A2 (en) * | 2006-10-02 | 2008-06-05 | Dow Global Technologies Inc. | High alcohol-content foams |
| US20080146820A1 (en) * | 2006-12-15 | 2008-06-19 | Axel Hans-Joachim Herzog | Phosphate fluorosurfactant and siloxane surfactant |
| US8580860B2 (en) * | 2007-02-23 | 2013-11-12 | Gojo Industries, Inc. | Foamable alcoholic composition |
| CA2621986A1 (en) | 2007-02-23 | 2008-08-23 | Gojo Industries, Inc. | Foamable alcoholic composition |
| EP2142687B1 (en) | 2007-04-17 | 2014-04-02 | Stellenbosch University | A process for the production of fibres |
| US8333954B2 (en) * | 2007-04-30 | 2012-12-18 | Kimberly-Clark Worldwide, Inc. | Foamable sanitizing compositions |
| DE102007029735A1 (en) * | 2007-06-25 | 2009-01-08 | Beiersdorf Ag | Copolymer with water-soluble lipids |
| EP2011471A1 (en) * | 2007-07-02 | 2009-01-07 | Johnson & Johnson Consumer France SAS | Foaming oil compositions |
| US8053399B2 (en) * | 2007-08-30 | 2011-11-08 | Kimberly-Clark Worldwide, Inc. | Foamable compositions |
| EP2212409B1 (en) * | 2007-11-06 | 2017-08-16 | Rhodia Opérations | Copolymer for treatment of laundry or hard surface |
| PT2135538E (en) * | 2008-06-20 | 2012-01-06 | Gojo Ind Inc | Diaphragm foam pump |
| US7842725B2 (en) | 2008-07-24 | 2010-11-30 | Ecolab USA, Inc. | Foaming alcohol compositions with selected dimethicone surfactants |
| US8846063B2 (en) * | 2008-12-16 | 2014-09-30 | Kimberly-Clark Worldwide, Inc. | Personal care composition containing a volatile and a terpene alcohol |
| AU2010202421B2 (en) | 2009-06-15 | 2014-05-08 | Gojo Industries, Inc. | Method and compositions for use with gel dispensers |
| DE102010004950A1 (en) * | 2010-01-18 | 2011-07-21 | Remis Gesellschaft für Entwicklung und Vertrieb von technischen Elementen mbH, 50829 | Cooling shelf with door device |
| UA108114C2 (en) * | 2010-08-06 | 2015-03-25 | Басф Се | Use of co-polymer containing n-vinyl lactam/vinylimidazone as dispersing agent |
| US9089129B2 (en) * | 2011-10-07 | 2015-07-28 | American Sterilizer Company | Non-aerosol foaming alcohol hand sanitizer |
| US8304375B1 (en) * | 2011-10-13 | 2012-11-06 | Kimberly-Clark Worldwide, Inc. | Foaming formulations including silicone polyesters |
| US8865195B2 (en) * | 2011-10-13 | 2014-10-21 | Kimberly-Clark Worldwide, Inc. | Foaming formulations and cleansing products including silicone polyesters |
| WO2013096580A2 (en) * | 2011-12-23 | 2013-06-27 | Gojo Industries, Inc. | Foamable alcoholic compositions with skin benefits |
| WO2013126696A2 (en) * | 2012-02-24 | 2013-08-29 | Gojo Industries, Inc. | Antimicrobial and foamable alcoholic compositions |
| CN104202980A (en) | 2012-03-30 | 2014-12-10 | Gojo工业公司 | Antimicrobial alcohol foam compositions and methods of preparation |
| US20130287712A1 (en) * | 2012-04-30 | 2013-10-31 | Kimberly-Clark Worldwide, Inc. | Foaming formulations including silicone-based polyurethanes |
| US9357771B2 (en) * | 2012-12-17 | 2016-06-07 | Kimberly-Clark Worldwide, Inc. | Foaming sanitizing formulations and products including a quaternary ammonium compound |
| AU2012275033B1 (en) | 2012-12-24 | 2013-09-26 | Konami Gaming, Inc. | Gaming machine and methods of allowing a player to play gaming machines having expanding symbol positions |
| NO3002246T3 (en) * | 2013-03-13 | 2018-04-07 | ||
| US9439841B2 (en) | 2013-06-06 | 2016-09-13 | Ecolab Usa Inc. | Alcohol based sanitizer with improved dermal compatibility and feel |
| JP5671118B1 (en) * | 2013-10-09 | 2015-02-18 | 近代化学株式会社 | Foamable composition for repelling harmful animals |
| WO2015061552A1 (en) * | 2013-10-23 | 2015-04-30 | Gojo Industries, Inc. | Foamable alcoholic compositions containing branched foaming surfactants |
| WO2015138926A1 (en) | 2014-03-14 | 2015-09-17 | Gojo Industries, Inc. | Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines |
| US10065199B2 (en) | 2015-11-13 | 2018-09-04 | Gojo Industries, Inc. | Foaming cartridge |
| WO2017087741A1 (en) | 2015-11-18 | 2017-05-26 | Gojo Industries, Inc. | A refill unit for a foam dispenser |
| US10080467B2 (en) | 2015-11-20 | 2018-09-25 | Gojo Industries, Inc. | Foam dispensing systems, pumps and refill units having high air to liquid ratios |
| US10080468B2 (en) | 2015-12-04 | 2018-09-25 | Gojo Industries, Inc. | Sequentially activated multi-diaphragm foam pumps, refill units and dispenser systems |
| CN106928957B (en) * | 2015-12-31 | 2019-08-02 | 北京爱普聚合科技有限公司 | A kind of foam fracturing structural type polymer foam stabilizer and preparation method thereof |
| EP3413770B1 (en) | 2016-02-11 | 2024-10-09 | Gojo Industries, Inc. | High quality non-aerosol hand sanitizing foam |
| US10441115B2 (en) | 2016-02-11 | 2019-10-15 | Gojo Industries, Inc. | High quality non-aerosol hand sanitizing foam |
| AU2017240064B8 (en) | 2016-03-31 | 2021-11-11 | Gojo Industries, Inc. | Antimicrobial peptide stimulating sanitizing composition |
| AU2017240069B2 (en) | 2016-03-31 | 2024-03-07 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| US10806769B2 (en) | 2016-03-31 | 2020-10-20 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| US10912426B2 (en) | 2016-04-06 | 2021-02-09 | Gojo Industries, Inc. | Sequentially activated multi-diaphragm foam pumps, refill units and dispenser systems |
| US10143339B2 (en) | 2016-04-06 | 2018-12-04 | Gojo Industries, Inc. | Sequentially activated multi-diaphragm foam pumps, refill units and dispenser systems |
| US20190142002A1 (en) * | 2016-04-25 | 2019-05-16 | Isp Investments Llc | An antimicrobial composition, process for preparing the same and method of use thereof |
| CA3043748A1 (en) | 2016-11-23 | 2018-05-31 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| EP3606343A1 (en) | 2017-04-04 | 2020-02-12 | Gojo Industries Inc | Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems |
| CN110996893A (en) * | 2017-09-30 | 2020-04-10 | 拜尔斯道夫日化(武汉)有限公司 | Hair styling compositions containing vinylcaprolactam/VP/dimethylaminoethyl methacrylate copolymer |
| CN108456595A (en) * | 2018-03-05 | 2018-08-28 | 湖州晶合化工有限公司 | A kind of cleaning agent for electronic material |
| US11653645B2 (en) | 2018-05-10 | 2023-05-23 | Protair-X Health Solutions Inc. | Foam sanitizer composition |
| CN109988312B (en) * | 2019-04-09 | 2023-04-11 | 深圳先进技术研究院 | Polyamide acid ester, preparation method, negative polyimide composition and application |
| CN110408042B (en) * | 2019-09-04 | 2021-08-24 | 北京化工大学常州先进材料研究院 | Preparation and application of an organosilicon grafted acrylate copolymer foam stabilizer |
| CN110982628A (en) * | 2019-11-28 | 2020-04-10 | 北京虾喜科技有限公司 | High-foaming detergent, preparation method thereof and car washing method |
| AU2021305611B2 (en) | 2020-07-06 | 2024-06-13 | Ecolab Usa Inc. | Foaming mixed alcohol/water compositions comprising a combination of alkyl siloxane and a hydrotrope/solubilizer |
| US12152220B2 (en) | 2020-07-06 | 2024-11-26 | Ecolab Usa Inc. | PEG-modified castor oil based compositions for microemulsifying and removing multiple oily soils |
| AU2021306707B2 (en) | 2020-07-06 | 2024-06-13 | Ecolab Usa Inc. | Foaming mixed alcohol/water compositions comprising a structured alkoxylated siloxane |
| US20220145217A1 (en) * | 2020-11-11 | 2022-05-12 | FogOff LLC | Anti-fogging formulation |
| CN116769454B (en) * | 2023-05-09 | 2024-11-19 | 中铁上海工程局集团市政环保工程有限公司 | Foaming agent for low-tension shield and preparation method thereof |
| CN117467423B (en) * | 2023-12-28 | 2024-03-05 | 成都华阳兴华化工有限公司 | High-temperature-resistant foam oil displacement agent |
Family Cites Families (161)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2054989A (en) * | 1933-12-30 | 1936-09-22 | Us Ind Alcohol Co | Compositions for application to the human skin |
| US2599140A (en) * | 1949-03-30 | 1952-06-03 | Benjamin Clayton | Iodine detergent |
| US2597702A (en) * | 1950-06-29 | 1952-05-20 | Du Pont | Fluoroalkylphosphoric compounds |
| US3131152A (en) * | 1960-06-13 | 1964-04-28 | Allied Chem | Foam producing formulations |
| US3131153A (en) * | 1961-10-25 | 1964-04-28 | Allied Chem | Foam producing compositions |
| US3709437A (en) * | 1968-09-23 | 1973-01-09 | Hershel Earl Wright | Method and device for producing foam |
| US3708435A (en) * | 1969-07-02 | 1973-01-02 | J Starkman | Method of cleaning human skin |
| US3787566A (en) * | 1969-07-29 | 1974-01-22 | Holliston Labor Inc | Disinfecting aerosol compositions |
| JPS5315525B2 (en) * | 1973-05-29 | 1978-05-25 | ||
| US3962150A (en) * | 1974-04-10 | 1976-06-08 | Richardson-Merrell Inc. | Foam producing cleansing compositions |
| IT1038373B (en) * | 1974-08-06 | 1979-11-20 | Rolls Royce Motors Ltd | FORMULATION FOR WINDOW CLEANING |
| US4018364A (en) * | 1975-04-03 | 1977-04-19 | Hershel Earl Wright | Foam dispensing device |
| US4171282A (en) * | 1977-12-07 | 1979-10-16 | Ciba-Geigy Corporation | Fluorinated nonionic surfactants |
| US4313978A (en) * | 1978-12-20 | 1982-02-02 | Minnesota Mining And Manufacturing Company | Antistatic compositions and treatment |
| US4311695A (en) * | 1979-12-03 | 1982-01-19 | Dow Corning Corporation | Personal-care emulsions comprising a siloxane-oxyalkylene copolymer |
| US4440652A (en) * | 1981-03-23 | 1984-04-03 | Texaco Development Corporation | Process for secondary recovery |
| US4336151A (en) * | 1981-07-06 | 1982-06-22 | American Cyanamid Company | Disinfectant/cleanser compositions exhibiting reduced eye irritancy potential |
| US4511486A (en) * | 1981-11-02 | 1985-04-16 | Richardson-Vicks Inc. | Method of cleaning dentures using aerated foams |
| US4440653A (en) * | 1982-03-08 | 1984-04-03 | Halliburton Company | Highly stable alcohol foams and methods of forming and using such foams |
| DE3485439D1 (en) * | 1983-10-24 | 1992-02-20 | Lockley Services Pty Ltd | FOAMABLE BIOCIDAL COMPOSITION. |
| KR920006539B1 (en) * | 1984-09-26 | 1992-08-08 | 안토니 그룩 브루노 | Antiseptic detergent composition |
| US4584189A (en) * | 1984-09-28 | 1986-04-22 | Hercules Incorporated | Bactericidal toothpastes |
| US4567038A (en) * | 1985-03-06 | 1986-01-28 | Revlon, Inc. | Sunscreen composition for hair protection |
| US4826828A (en) * | 1985-04-22 | 1989-05-02 | Avon Products, Inc. | Composition and method for reducing wrinkles |
| US5288486A (en) * | 1985-10-28 | 1994-02-22 | Calgon Corporation | Alcohol-based antimicrobial compositions |
| LU86429A1 (en) * | 1986-05-16 | 1987-12-16 | Oreal | COSMETIC COMPOSITIONS CONTAINING A CATIONIC POLYMER AND AN ANIONIC POLYMER AS A THICKENING AGENT |
| JPH0678217B2 (en) * | 1986-09-18 | 1994-10-05 | 花王株式会社 | Emulsified hair cosmetics |
| US4906459A (en) * | 1987-10-23 | 1990-03-06 | The Procter & Gamble Company | Hair care compositions |
| US4897262A (en) * | 1988-03-22 | 1990-01-30 | Playtex Jhirmack, Inc. | Non-aerosol hair spray composition |
| DE3905063A1 (en) * | 1989-02-18 | 1990-08-23 | Schuelke & Mayr Gmbh | SPREADABLE FLAIN DISINFECTANT |
| GB8904938D0 (en) * | 1989-03-03 | 1989-04-12 | Unilever Plc | Detergent bar |
| US5015228A (en) * | 1989-06-05 | 1991-05-14 | Eastman Kodak Company | Sterilizing dressing device and method for skin puncture |
| US4956170A (en) * | 1989-06-28 | 1990-09-11 | S. C. Johnson & Son, Inc. | Skin moisturizing/conditioning antimicrobial alcoholic gels |
| US5560859A (en) * | 1989-07-26 | 1996-10-01 | Pfizer Inc. | Post foaming gel shaving composition |
| US5100658A (en) * | 1989-08-07 | 1992-03-31 | The Procter & Gamble Company | Vehicle systems for use in cosmetic compositions |
| US5104646A (en) * | 1989-08-07 | 1992-04-14 | The Procter & Gamble Company | Vehicle systems for use in cosmetic compositions |
| US5290555A (en) * | 1989-09-14 | 1994-03-01 | Revlon Consumer Products Corporation | Cosmetic compositions with structural color |
| FR2657617B1 (en) * | 1990-01-31 | 1994-03-25 | Oreal | OIL-IN-WATER EMULSIONS BASED ON INSOLUBLE SILICONES AND AN EMULSIFYING AGENT OF THE CARBOXYLIC ACID POLYOXYALKYLENE ACID TYPE, AND THEIR APPLICATION IN COSMETICS AND DERMATOLOGY. |
| FR2658076B1 (en) * | 1990-02-12 | 1992-06-12 | Sanofi Sa | COSMETIC COMPOSITION CONTAINING COPOLYMERS OF AMINO ACIDS, USEFUL AS A MOISTURIZING AGENT. |
| US4986922A (en) * | 1990-04-04 | 1991-01-22 | Dow Corning Corporation | Softening compositions including quaternary ammonium functional siloxanes |
| US5167950A (en) * | 1991-03-28 | 1992-12-01 | S. C. Johnson & Son | High alcohol content aerosol antimicrobial mousse |
| US5415811A (en) * | 1991-04-09 | 1995-05-16 | E And R Investments | Cleaning composition and method for utilizing same |
| CA2074293C (en) * | 1991-07-25 | 2002-03-19 | John R. Horoschak | Water-based hair fixative composition |
| JP2944753B2 (en) * | 1991-08-19 | 1999-09-06 | ザ、プロクター、エンド、ギャンブル、カンパニー | Hair spray composition |
| GB9118979D0 (en) * | 1991-09-04 | 1991-10-23 | Unilever Plc | Cosmetic composition |
| US5494533A (en) * | 1991-12-12 | 1996-02-27 | Richardson-Vicks, Inc. | Method for personal cleansing |
| WO1993021899A1 (en) * | 1992-05-05 | 1993-11-11 | The Procter & Gamble Company | Acne treating composition |
| US5690921A (en) * | 1992-10-15 | 1997-11-25 | Wella Aktiengesellschaft | Hair fixing composition in the form of an aqueous solution, foam or gel |
| JPH06279268A (en) * | 1993-01-27 | 1994-10-04 | Takeda Chem Ind Ltd | Disinfecting and sterilizing agent and aerosol composition containing the same |
| JPH06327750A (en) * | 1993-05-24 | 1994-11-29 | Osaka Zosenjo:Kk | Aerosol composition for sterilization and disinfection |
| US5484597A (en) * | 1993-07-30 | 1996-01-16 | Chesebrough-Pond's Usa Co. | Clear hydroalcholic cosmetic microemulsions |
| SG52692A1 (en) * | 1993-08-23 | 1998-09-28 | Procter & Gamble | Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same |
| WO1995012395A1 (en) * | 1993-11-05 | 1995-05-11 | E.R. Squibb And Sons, Inc. | Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol |
| FR2717075B1 (en) * | 1994-03-14 | 1996-04-05 | Oreal | Aqueous organopolysiloxane makeup gel. |
| US5445288A (en) * | 1994-04-05 | 1995-08-29 | Sprintvest Corporation Nv | Liquid dispenser for dispensing foam |
| WO1995031962A1 (en) * | 1994-05-20 | 1995-11-30 | Gojo Industries, Inc. | Antimicrobial cleaning composition containing chlorhexidine, anamphoteric and an alkylpolyglucoside |
| CA2151774C (en) * | 1994-06-27 | 1999-04-06 | Minh Quang Hoang | Skin disinfecting formulations |
| US5540853A (en) * | 1994-10-20 | 1996-07-30 | The Procter & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
| CA2206315A1 (en) * | 1994-11-29 | 1996-06-06 | Hisamitsu Pharmaceutical Co., Inc. | Antibacterial preparation or bactericide comprising 2-aminothiazole derivative and/or salt thereof |
| SE506265C2 (en) * | 1995-04-28 | 1997-11-24 | Akzo Nobel Nv | Aqueous composition containing an alkyl glycoside and its use as a wetting agent |
| US5625659A (en) * | 1995-05-19 | 1997-04-29 | Gojo Industries, Inc. | Method and apparatus for electronically measuring dispenser usage |
| US6623744B2 (en) * | 1995-06-22 | 2003-09-23 | 3M Innovative Properties Company | Stable hydroalcoholic compositions |
| CA2224702C (en) * | 1995-06-22 | 2013-01-08 | Robert A. Asmus | Stable hydroalcoholic compositions |
| AU715827B2 (en) * | 1995-06-22 | 2000-02-10 | Minnesota Mining And Manufacturing Company | Stable hydroalcoholic compositions |
| US5607980A (en) * | 1995-07-24 | 1997-03-04 | The Procter & Gamble Company | Topical compositions having improved skin feel |
| EP0758641B1 (en) * | 1995-08-11 | 2000-08-30 | Daicel Chemical Industries, Ltd. | A fatty acid esters composition of a polyglycerine, a process for the preparation thereof, a process for the preparation of a highly-purified fatty acid esters composition of a polyglycerine, a highly-purified fatty acid esters composition of a polyglycerine, an additive for food-stuffs, a resin composition, and a composition for cosmetics or detergents |
| DE19531893A1 (en) * | 1995-08-30 | 1997-03-06 | Bayer Ag | Itching, cosmetic and / or pharmaceutical compositions |
| EP0862407A4 (en) * | 1995-09-22 | 1999-03-03 | Phylomed Corp | Topical formulations and delivery systems |
| US5733535A (en) * | 1995-10-25 | 1998-03-31 | The Procter & Gamble Co. | Topical compositions containing N-acetylcysteine and odor masking materials |
| US5718353A (en) * | 1996-05-08 | 1998-02-17 | Gojo Industries, Inc. | Towelette dispensing closure assembly |
| AU726543B2 (en) * | 1996-07-10 | 2000-11-09 | S.C. Johnson & Son, Inc. | Triclosan skin wash with enhanced efficacy |
| US5756077A (en) * | 1996-09-13 | 1998-05-26 | Avlon Industries, Inc. | Hair protectant composition and process for preserving chemically processed hair during subsequent chemical processing |
| US6039965A (en) * | 1996-09-27 | 2000-03-21 | Calgon Corporation | Surfanctants for reducing bacterial adhesion onto surfaces |
| US6019997A (en) * | 1997-01-09 | 2000-02-01 | Minnesota Mining And Manufacturing | Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents |
| US6582711B1 (en) * | 1997-01-09 | 2003-06-24 | 3M Innovative Properties Company | Hydroalcoholic compositions thickened using polymers |
| US5908619A (en) * | 1997-01-09 | 1999-06-01 | Minnesota Mining And Manufacturing Company | Hydroalcoholic compositions thickened using surfactant/polymer complexes |
| US5863884A (en) * | 1997-06-11 | 1999-01-26 | Lafreniere; Donald R. T. | Silicone and adhesive removal composition |
| GB2327881A (en) * | 1997-08-06 | 1999-02-10 | Reckitt & Colman Inc | Control of dust particles |
| DE19748921C2 (en) * | 1997-10-30 | 2001-02-22 | Stockhausen Chem Fab Gmbh | Skin-friendly hand cleaners, especially rough hand cleaners |
| US6022551A (en) * | 1998-01-20 | 2000-02-08 | Ethicon, Inc. | Antimicrobial composition |
| US20020022660A1 (en) * | 1998-01-20 | 2002-02-21 | Hanuman B. Jampani | Deep penetrating antimicrobial compositions |
| US6156222A (en) * | 1998-05-08 | 2000-12-05 | Ciba Specialty Chemicals Corporation | Poly-perfluoroalkyl substituted polyamines as grease proofing agents for paper and foam stabilizers in aqueous fire-fighting foams |
| US6531303B1 (en) * | 1998-07-06 | 2003-03-11 | Arkion Life Sciences Llc | Method of producing geranylgeraniol |
| JP2000026249A (en) * | 1998-07-14 | 2000-01-25 | Nof Corp | Hair cleaning composition |
| US6333039B1 (en) * | 1998-09-25 | 2001-12-25 | Gojo Industries, Inc. | Opaque skin sanitizing composition |
| US6887494B2 (en) * | 1998-10-02 | 2005-05-03 | Us Cosmetics | Pigments and extender pigments with enhanced skin adhesion for cosmetic preparations |
| US6287546B1 (en) * | 1998-10-09 | 2001-09-11 | Colgate-Palmolive Company | Shampoos with stabilizers |
| US6143704A (en) * | 1998-10-13 | 2000-11-07 | Lever Brothers Company, Division Of Conopco, Inc. | Soap bars with little or no synthetic surfactant comprising organic salts |
| FR2786392B1 (en) * | 1998-11-26 | 2006-08-25 | Oreal | HAIR COMPOSITION COMPRISING A POLYMER WITH PARTICULAR CHARACTERISTICS AND A NON-IONIC POLYMER |
| US6262128B1 (en) * | 1998-12-16 | 2001-07-17 | 3M Innovative Properties Company | Aqueous foaming compositions, foam compositions, and preparation of foam compositions |
| US6703007B2 (en) * | 1999-01-08 | 2004-03-09 | The Procter & Gamble Company | Topical compositions comprising functional nucleophiles protected by phosphorus-containing moieties |
| US6183766B1 (en) * | 1999-02-12 | 2001-02-06 | The Procter & Gamble Company | Skin sanitizing compositions |
| US6065639A (en) * | 1999-02-26 | 2000-05-23 | Gojo Industries, Inc. | Multiple use wash counter and timer |
| US6395264B1 (en) * | 1999-05-07 | 2002-05-28 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Low VOC hair spray compositions having enhanced styling benefits |
| US6479442B1 (en) * | 1999-05-05 | 2002-11-12 | Access Business Group International Llc | Hydrotrope and skin conditioning agents for use in liquid detergent compositions |
| US6518228B1 (en) * | 1999-05-27 | 2003-02-11 | Clairol Incorporated | Ultra-mild, clear, aqueous, foamable skin cleanser |
| US20020160924A1 (en) * | 1999-06-15 | 2002-10-31 | The Procter & Gamble Company | Cleaning compositions |
| US6358914B1 (en) * | 1999-06-17 | 2002-03-19 | Gladys S. Gabriel | Surfactant compositions with enhanced soil release properties containing a cationic gemini surfactant |
| US6524594B1 (en) * | 1999-06-23 | 2003-02-25 | Johnson & Johnson Consumer Companies, Inc. | Foaming oil gel compositions |
| US6685952B1 (en) * | 1999-06-25 | 2004-02-03 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care compositions and methods-high internal phase water-in-volatile silicone oil systems |
| US6762158B2 (en) * | 1999-07-01 | 2004-07-13 | Johnson & Johnson Consumer Companies, Inc. | Personal care compositions comprising liquid ester mixtures |
| US6297205B1 (en) * | 1999-08-30 | 2001-10-02 | Amway Corporation | Monohydric alcohol-free transparent moisturizing bar soap |
| DE19943668A1 (en) * | 1999-09-13 | 2001-03-15 | Rwe Dea Ag | Surfactant composition containing gemini surfactants and co-amphiphiles, their preparation and their use |
| GB0001021D0 (en) * | 2000-01-14 | 2000-03-08 | Dow Corning Sa | Foam control agents |
| US6555508B1 (en) * | 2000-02-17 | 2003-04-29 | Leonard Paul | Liquid foaming soap compositions |
| DE10009252A1 (en) * | 2000-03-01 | 2001-09-06 | Henkel Kgaa | Cleaning gels producing heat of hydration on mixing with water and especially for use on the skin, contain water-miscible hydroxy compounds, surfactants, salts of negative solution enthalpy and thickeners |
| MXPA02010249A (en) * | 2000-04-17 | 2004-09-06 | Unilever Nv | Substantially dry cleansing product of improved latherability and wet flexibility. |
| US6342470B1 (en) * | 2000-04-26 | 2002-01-29 | Unilever Home & Personal Care Usa | Bar comprising soap, fatty acid, polyalkylene glycol and protic acid salts in critical ratios and providing enhanced skin care benefits |
| US6696053B1 (en) * | 2000-05-04 | 2004-02-24 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Leave-on or rinse-out hair care conditioner compositions containing silicone quaternary compounds and thickeners |
| US7264678B2 (en) * | 2000-06-14 | 2007-09-04 | The Procter & Gamble Company | Process for cleaning a surface |
| US6410005B1 (en) * | 2000-06-15 | 2002-06-25 | Pmd Holdings Corp. | Branched/block copolymers for treatment of keratinous substrates |
| US6537952B2 (en) * | 2000-08-31 | 2003-03-25 | Unilever Home And Personal Care, Usa Division Of Conopco, Inc. | Foaming anti-bacterial cleansing skin product with low water insoluble emollients and foam dispenser |
| US6617294B2 (en) * | 2000-10-20 | 2003-09-09 | Vinod K. Narula | Waterless sanitizing hand cleanser |
| WO2002034045A1 (en) * | 2000-10-20 | 2002-05-02 | Narula Vinod K | Sanitizing hand cleanser |
| US6383505B1 (en) * | 2000-11-09 | 2002-05-07 | Steris Inc | Fast-acting antimicrobial lotion with enhanced efficacy |
| EP1351658B1 (en) * | 2001-01-16 | 2005-03-02 | Unilever N.V. | Oral composition |
| US6524494B2 (en) * | 2001-02-02 | 2003-02-25 | Givaudan Sa | Compositions to enhance fabric freshness and appearance |
| US6551605B2 (en) * | 2001-04-06 | 2003-04-22 | Haarmann & Reimer | Diesters or polyesters of naphthalene dicarboxylic acid as solubilizer/stabilizer for retinoids |
| US6730621B2 (en) * | 2001-05-14 | 2004-05-04 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Damp cleansing wipe |
| EP1275370A1 (en) * | 2001-07-13 | 2003-01-15 | Johnson and Johnson GmbH | Products comprising a sheet and a lipid and aqueous phase |
| US7166435B2 (en) * | 2001-08-06 | 2007-01-23 | The Quigley Corporation | Compositions and methods for reducing the transmissivity of illnesses |
| DE10141324A1 (en) * | 2001-08-28 | 2003-04-24 | Sasol Germany Gmbh | Sprayable O / W emulsions of low viscosity |
| US7973235B2 (en) * | 2001-09-18 | 2011-07-05 | Ut-Batelle, Llc | Hybrid solar lighting distribution systems and components |
| DE10147186A1 (en) * | 2001-09-25 | 2003-04-24 | Beiersdorf Ag | Synergistic antimicrobial composition, useful e.g. as cosmetic preservative and for treating skin disorders, comprises polyhexamethylene biguanide and distearyldimethylammonium chloride |
| US6846846B2 (en) * | 2001-10-23 | 2005-01-25 | The Trustees Of Columbia University In The City Of New York | Gentle-acting skin disinfectants |
| US6884763B2 (en) * | 2001-10-30 | 2005-04-26 | Permatex, Inc. | Waterless hand cleaner containing plant derived natural essential oil |
| US6875539B2 (en) * | 2002-01-18 | 2005-04-05 | Heiner Ophardt | Combination liquid dispenser and electrochemical cell |
| EP1480517A4 (en) * | 2002-02-07 | 2007-08-22 | Univ Columbia | ZINC SALT COMPOSITIONS AGAINST MUCOSAL IRRITATION FROM SPERMICIDES AND MICROBICIDES |
| EP1354939A1 (en) * | 2002-04-19 | 2003-10-22 | The Procter & Gamble Company | Pouched cleaning compositions |
| US6696397B2 (en) * | 2002-04-30 | 2004-02-24 | Victor Staats | Antibacterial soap |
| US20040001797A1 (en) * | 2002-06-21 | 2004-01-01 | Abel Saud | Antimicrobial compositions, products and methods employing same |
| US6818603B2 (en) * | 2002-08-14 | 2004-11-16 | Johnson & Johnson Consumer Companies, Inc. | Cleansing bar containing discrete elements |
| US6706675B1 (en) * | 2002-08-30 | 2004-03-16 | The Dial Corporation | Translucent soap bar composition and method of making the same |
| US6780826B2 (en) * | 2002-09-11 | 2004-08-24 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Oil-containing personal wash compositions or emulsions comprising particles of high refractive index and defined thickness, geometry and size |
| US6759376B2 (en) * | 2002-09-11 | 2004-07-06 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Oil-containing personal wash liquid compositions or emulsions comprising particles of high refractive index and defined thickness, geometry and size |
| US7049436B2 (en) * | 2002-10-09 | 2006-05-23 | Bj Services Company | Carbon dioxide compatible non-aqueous crosslinked fracturing fluids and methods for their use |
| US7666826B2 (en) * | 2002-11-27 | 2010-02-23 | Ecolab Inc. | Foam dispenser for use in foaming cleaning composition |
| US6723689B1 (en) * | 2003-01-08 | 2004-04-20 | Becton Dickinson And Company | Emollient alcohol skin disinfecting formulation |
| CA2424003A1 (en) * | 2003-03-28 | 2004-09-28 | Austin & Repatriation Medical Centre | Anti-microbial topical composition comprising alcohol and chlorhexidine salt |
| DE10333443A1 (en) * | 2003-07-23 | 2005-02-10 | Goldschmidt Ag | Emulsifier for low-viscosity W / O emulsions based on partially crosslinked polyglycerol esters of polyhydroxystearic acid |
| US7959903B2 (en) * | 2003-08-01 | 2011-06-14 | L'oreal | Oil-in-water photoprotective emulsions containing gemini surfactants and associative polymers |
| WO2005030917A1 (en) * | 2003-09-29 | 2005-04-07 | Ethena Healthcare Inc. | High alcohol content gel-like and foaming compositions |
| JP2005162703A (en) * | 2003-12-05 | 2005-06-23 | Pola Chem Ind Inc | Facial wash |
| DE102004016683A1 (en) * | 2004-04-05 | 2005-10-27 | Wella Ag | Permanently foamed composition |
| DE102004026684A1 (en) * | 2004-05-28 | 2005-12-29 | Stockhausen Gmbh | Skin cleansing preparations, in particular for removing printing inks and / or ink soils |
| US6998374B2 (en) * | 2004-06-14 | 2006-02-14 | Carl Niedbala | Composition and method for cleaning gelatin encapsulated products comprising a non-volatile silicone/volatile silicone mixture |
| WO2006055017A1 (en) * | 2004-11-16 | 2006-05-26 | John T Novak | Foamable alcohol |
| US20060104919A1 (en) * | 2004-11-16 | 2006-05-18 | Novak John T | Foamable alcohol |
| DE102004055549A1 (en) * | 2004-11-17 | 2006-05-18 | Goldschmidt Gmbh | Preparation of betaine solution by quaternizing tertiary amine nitrogen containing compounds with omega-halogen carbonic acid, useful e.g. to produce washing agents, comprises adding micellar thickener to mixture before/during the reaction |
| US20060110416A1 (en) * | 2004-11-23 | 2006-05-25 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Hydroalcoholic cosmetic compositions |
| DE102004062775A1 (en) * | 2004-12-21 | 2006-06-29 | Stockhausen Gmbh | Alcoholic pump foam |
| JP2008531740A (en) * | 2005-03-07 | 2008-08-14 | デブ ワールドワイド ヘルスケア インコーポレーテッド | High alcohol content foamable composition containing a silicone based surfactant |
| US7651990B2 (en) * | 2005-06-13 | 2010-01-26 | 3M Innovative Properties Company | Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use |
| DE102005051222A1 (en) * | 2005-10-26 | 2007-05-03 | Goldschmidt Gmbh | Liquid, cold-processable oil-in-water emulsifier system for, e.g. cosmetic preparation, has polyethylene glycol-free emulsifier base of polyol partial ester(s) and acid partial ester(s) carrying neutralizable or neutralized acid functions |
| US7164041B1 (en) * | 2005-11-17 | 2007-01-16 | 3M Innovative Properties Company | Fluorinated Gemini surfactants |
| US8815224B2 (en) * | 2005-12-21 | 2014-08-26 | Avon Products, Inc | Hair treatment compositions |
| US7723279B2 (en) * | 2006-08-23 | 2010-05-25 | The Clorox Company | Foamable compositions containing alcohol |
| MX2009004246A (en) * | 2006-10-27 | 2009-05-14 | 3M Innovative Properties Co | Antimicrobial compositions. |
| US8333954B2 (en) * | 2007-04-30 | 2012-12-18 | Kimberly-Clark Worldwide, Inc. | Foamable sanitizing compositions |
| DE102007040000A1 (en) * | 2007-08-23 | 2009-02-26 | Evonik Goldschmidt Gmbh | Zwitterionic compounds and their use |
| US7842725B2 (en) * | 2008-07-24 | 2010-11-30 | Ecolab USA, Inc. | Foaming alcohol compositions with selected dimethicone surfactants |
-
2006
- 2006-05-22 US US11/438,664 patent/US20070148101A1/en not_active Abandoned
- 2006-12-15 MY MYPI20064685A patent/MY148766A/en unknown
- 2006-12-15 AU AU2006252070A patent/AU2006252070C1/en not_active Ceased
- 2006-12-20 EP EP10182589A patent/EP2264135A3/en not_active Withdrawn
- 2006-12-20 ES ES06256249T patent/ES2330665T3/en active Active
- 2006-12-20 EP EP06256249A patent/EP1811013B1/en not_active Revoked
- 2006-12-20 AT AT06256249T patent/ATE439417T1/en not_active IP Right Cessation
- 2006-12-20 DE DE602006008411T patent/DE602006008411D1/en active Active
- 2006-12-20 EP EP09166152A patent/EP2113556A3/en not_active Withdrawn
- 2006-12-21 JP JP2006343712A patent/JP2007176940A/en active Pending
- 2006-12-25 TW TW095148788A patent/TWI394831B/en not_active IP Right Cessation
- 2006-12-25 TW TW102105324A patent/TWI476278B/en not_active IP Right Cessation
- 2006-12-27 BR BRPI0605381-5A patent/BRPI0605381A/en not_active Application Discontinuation
- 2006-12-27 KR KR1020060135263A patent/KR101380039B1/en not_active Expired - Fee Related
- 2006-12-27 CA CA 2572107 patent/CA2572107C/en not_active Expired - Fee Related
- 2006-12-28 CN CN2006101727150A patent/CN101003768B/en not_active Expired - Fee Related
- 2006-12-28 CN CN2010105093216A patent/CN101955853A/en active Pending
-
2010
- 2010-12-22 US US12/975,454 patent/US20110104079A1/en not_active Abandoned
-
2013
- 2013-11-08 US US14/075,291 patent/US20140094525A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2264135A3 (en) | 2012-05-02 |
| DE602006008411D1 (en) | 2009-09-24 |
| BRPI0605381A (en) | 2007-10-16 |
| US20140094525A1 (en) | 2014-04-03 |
| US20070148101A1 (en) | 2007-06-28 |
| TWI476278B (en) | 2015-03-11 |
| EP1811013B1 (en) | 2009-08-12 |
| EP1811013A1 (en) | 2007-07-25 |
| CN101003768A (en) | 2007-07-25 |
| ES2330665T3 (en) | 2009-12-14 |
| TW200738869A (en) | 2007-10-16 |
| MY148766A (en) | 2013-05-31 |
| EP2264135A2 (en) | 2010-12-22 |
| HK1106269A1 (en) | 2008-03-07 |
| CN101003768B (en) | 2013-12-18 |
| EP2113556A3 (en) | 2010-03-31 |
| KR101380039B1 (en) | 2014-04-11 |
| ATE439417T1 (en) | 2009-08-15 |
| JP2007176940A (en) | 2007-07-12 |
| CN101955853A (en) | 2011-01-26 |
| AU2006252070C1 (en) | 2013-12-19 |
| AU2006252070A1 (en) | 2007-07-12 |
| CA2572107C (en) | 2015-04-21 |
| AU2006252070B2 (en) | 2011-08-11 |
| KR20070070103A (en) | 2007-07-03 |
| EP2113556A2 (en) | 2009-11-04 |
| TWI394831B (en) | 2013-05-01 |
| CA2572107A1 (en) | 2007-06-28 |
| US20110104079A1 (en) | 2011-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI476278B (en) | Foamable alcoholic composition | |
| US8313758B2 (en) | Method of producing high alcohol content foaming compositions with silicone-based surfactants | |
| US8580860B2 (en) | Foamable alcoholic composition | |
| JP6654615B2 (en) | Antibacterial and effervescent alcohol composition | |
| TW201340988A (en) | Foamable alcoholic compositions with skin benefits | |
| CA2621986A1 (en) | Foamable alcoholic composition | |
| CN101310703A (en) | Foamable alcoholic composition | |
| AU2011224144C1 (en) | Foamable alcoholic composition | |
| HK1106269B (en) | Foamable alcoholic composition | |
| HK1138032A (en) | Foamable alcoholic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |